<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Plants (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Plants (Basel)</journal-id><journal-id journal-id-type="pmc-domain-id">2909</journal-id><journal-id journal-id-type="pmc-domain">plants</journal-id><journal-id journal-id-type="publisher-id">plants</journal-id><journal-title-group><journal-title>Plants</journal-title></journal-title-group><issn pub-type="epub">2223-7747</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430367</article-id><article-id pub-id-type="pmcid-ver">PMC12430367.1</article-id><article-id pub-id-type="pmcaid">12430367</article-id><article-id pub-id-type="pmcaiid">12430367</article-id><article-id pub-id-type="doi">10.3390/plants14172639</article-id><article-id pub-id-type="publisher-id">plants-14-02639</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>In Vivo Investigation of Cardioprotective Effects of <italic toggle="yes">Melilotus officinalis</italic> and <italic toggle="yes">Melilotus albus</italic> Aerial Parts Extracts for Potential Therapeutic Application</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5435-4600</contrib-id><name name-style="western"><surname>Toiu</surname><given-names initials="A">Anca</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-plants-14-02639" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4865-0777</contrib-id><name name-style="western"><surname>Vlase</surname><given-names initials="AM">Ana-Maria</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af2-plants-14-02639" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0664-3387</contrib-id><name name-style="western"><surname>Vlase</surname><given-names initials="L">Laurian</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af3-plants-14-02639" ref-type="aff">3</xref><xref rid="c1-plants-14-02639" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4984-8216</contrib-id><name name-style="western"><surname>Casian</surname><given-names initials="T">Tibor</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af3-plants-14-02639" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9052-6844</contrib-id><name name-style="western"><surname>P&#226;rvu</surname><given-names initials="AE">Alina Elena</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af4-plants-14-02639" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7660-9993</contrib-id><name name-style="western"><surname>Oniga</surname><given-names initials="I">Ilioara</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-plants-14-02639" ref-type="aff">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Nicoletti</surname><given-names initials="M">Marcello</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-plants-14-02639"><label>1</label>Department of Pharmacognosy, Faculty of Pharmacy, &#8220;Iuliu Ha&#539;ieganu&#8221; University of Medicine and Pharmacy, Ion Creang&#259; Street 12, 400010 Cluj-Napoca, Romania; <email>atoiu@umfcluj.ro</email> (A.T.); <email>ioniga@umfcluj.ro</email> (I.O.)</aff><aff id="af2-plants-14-02639"><label>2</label>Department of Pharmaceutical Botany, Faculty of Pharmacy, &#8220;Iuliu Ha&#355;ieganu&#8221; University of Medicine and Pharmacy, 41 V. Babes St., 400012 Cluj-Napoca, Romania; <email>gheldiu.ana@umfcluj.ro</email></aff><aff id="af3-plants-14-02639"><label>3</label>Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, &#8220;Iuliu Ha&#355;ieganu&#8221; University of Medicine and Pharmacy, 41 V. Babes St., 400012 Cluj-Napoca, Romania; <email>casian.tibor@umfcluj.ro</email></aff><aff id="af4-plants-14-02639"><label>4</label>Department of Morpho-Functional Sciences, Discipline of Pathophysiology, Faculty of Medicine, Iuliu Ha&#355;ieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania; <email>parvualinaelena@umfcluj.ro</email></aff><author-notes><corresp id="c1-plants-14-02639"><label>*</label>Correspondence: <email>laurian.vlase@umfcluj.ro</email></corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>14</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">496803</issue-id><elocation-id>2639</elocation-id><history><date date-type="received"><day>18</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>15</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>25</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="plants-14-02639.pdf"/><abstract><p>Globally, cardiovascular diseases represent a major cause of morbidity and mortality, despite the availability of preventive, diagnostic, and therapeutic measures in contemporary allopathic medicine. In accordance with their ethnomedical applications, herbal medicines may offer valuable options for the prevention, treatment, and management of cardiovascular disorders. Considering that cardioprotective effects are associated with antioxidant mechanisms, and that our knowledge of the antioxidant properties of polyphenolic compounds, as well as of the effects of <italic toggle="yes">Melilotus</italic> species on the heart, is limited, the present study aimed to evaluate the cardioprotective potential of hydroalcoholic extracts of <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> aerial parts. The extracts were evaluated for total phenolic content (TPC), total flavonoid content (TFC), and total coumarin content (TCC) by spectrophotometric methods and by LC-MS/MS. The effect of pretreatment with <italic toggle="yes">Melilotus</italic> sp. extracts on the isoprenaline-induced infarct-like lesion in rats was evaluated by ECG monitoring and the assessment of serum oxidative stress markers and serum cardiac injury markers. Various polyphenolic compounds were identified by LC-MS/MS in <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> aerial parts: catechin, syringic acid, protocatechuic acid, and vanillic acid. Gallic acid and chlorogenic acid were found only in <italic toggle="yes">M. officinalis</italic>. The extracts showed good in vivo antioxidant activity: <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> extracts induced a significant decrease in the levels of oxidative stress index (OSI) and total oxidant status (TOS), while pre-treatment with <italic toggle="yes">M. albus</italic> extract induced a significant reduction in nitric oxide production, and pretreatment with <italic toggle="yes">M. officinalis</italic> increased total thiols (SH) levels. In the same way, ECG and cardiac injury markers were also improved. These results show that <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> extracts may exert cardioprotective effects against myocardial ischemia by reducing oxidative stress.</p></abstract><kwd-group><kwd><italic toggle="yes">Melilotus officinalis</italic></kwd><kwd><italic toggle="yes">Melilotus albus</italic></kwd><kwd>cardioprotective agents</kwd><kwd>antioxidants</kwd><kwd>polyphenolic compounds</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-plants-14-02639"><title>1. Introduction</title><p>Certain cardiovascular diseases (CVDs), notably ischemic heart disease (IHD) and hypertension, are the primary cause of mortality in industrialized countries, and their prevalence is growing all over the world [<xref rid="B1-plants-14-02639" ref-type="bibr">1</xref>,<xref rid="B2-plants-14-02639" ref-type="bibr">2</xref>]. Myocardial infarction (MI) is an acute condition of myocardial necrosis which manifests as a disproportion between myocardial demands and coronary blood supply. Several biochemical mechanisms are implicated: an increased generation of reactive oxygen species (ROS); the oxidative deterioration of membrane proteins, carbohydrates, lipids, and DNA; inflammatory processes; and important changes in the structural, mechanical, electrical, and biochemical properties of the heart [<xref rid="B1-plants-14-02639" ref-type="bibr">1</xref>,<xref rid="B3-plants-14-02639" ref-type="bibr">3</xref>,<xref rid="B4-plants-14-02639" ref-type="bibr">4</xref>].</p><p>Many important phytochemicals from medicinal plants have been shown to alleviate the pathophysiology of acute myocardial infarction, improve conventional treatment, and offer better management of the disease with fewer adverse effects, as demonstrated in various studies [<xref rid="B1-plants-14-02639" ref-type="bibr">1</xref>,<xref rid="B2-plants-14-02639" ref-type="bibr">2</xref>,<xref rid="B4-plants-14-02639" ref-type="bibr">4</xref>]. Free radical scavengers and antioxidant compounds could help the myocardial cells recover from the induced programmed cell death; therefore, these compounds might be used as part of a preventive approach to overcome myocardial ischemia. Dietary administration of natural products has been proven to improve endothelial function and lipid metabolism, as well as to modulate oxidative stress pathways in experimental and clinical models of cardiovascular dysfunction [<xref rid="B5-plants-14-02639" ref-type="bibr">5</xref>]. Evidence for the role of polyphenolic compounds in the prevention of degenerative diseases due to their antioxidant activity is emerging. Several mechanisms have been proposed to explain the cardioprotective activity of polyphenols, such as activation of AMP-activated protein kinase, nitric oxide synthase, and sirtuin 1, improvement of endothelial cell function, inhibition of angiotensin-converting enzyme and phosphate diesterase, fibrinolytic activity, and anti-platelet aggregation activity. Furthermore, polyphenolic compounds lower blood pressure; possess anti-inflammatory potential; improve insulin resistance, ventricular health, and plasma lipid markers; and reduce atherosclerosis, which will lower the risk of cardiovascular diseases [<xref rid="B6-plants-14-02639" ref-type="bibr">6</xref>].</p><p><italic toggle="yes">Melilotus</italic> species (Fabaceae family) are annual, biennial, or short-lived perennial herbs that occur frequently in spontaneous flora or are cultivated. In <italic toggle="yes">Flora Europaea</italic>, there are mentioned 16 species, while around 20&#8211;25 species are recognized worldwide [<xref rid="B7-plants-14-02639" ref-type="bibr">7</xref>,<xref rid="B8-plants-14-02639" ref-type="bibr">8</xref>]. In Romania there are five species: <italic toggle="yes">M. dentatus</italic>, <italic toggle="yes">M. albus</italic>, <italic toggle="yes">M. arenaria</italic>, <italic toggle="yes">M. Altissimus</italic>, and <italic toggle="yes">M. officinalis</italic> [<xref rid="B9-plants-14-02639" ref-type="bibr">9</xref>]. Research on bioactive compounds from <italic toggle="yes">Melilotus</italic> species has revealed the presence of coumarins, flavonoids, saponins, and steroids [<xref rid="B10-plants-14-02639" ref-type="bibr">10</xref>,<xref rid="B11-plants-14-02639" ref-type="bibr">11</xref>,<xref rid="B12-plants-14-02639" ref-type="bibr">12</xref>]. Used for centuries in traditional medicine for the treatment of arthritis, rheumatism, bronchitis, kidney stones, or palpitations, <italic toggle="yes">M. officinalis</italic> is the most studied species of this genus [<xref rid="B8-plants-14-02639" ref-type="bibr">8</xref>,<xref rid="B13-plants-14-02639" ref-type="bibr">13</xref>,<xref rid="B14-plants-14-02639" ref-type="bibr">14</xref>].</p><p>Several studies have shown the anti-inflammatory, antioxidant, and antiproliferative potential of <italic toggle="yes">M. officinalis</italic> aerial parts [<xref rid="B15-plants-14-02639" ref-type="bibr">15</xref>,<xref rid="B16-plants-14-02639" ref-type="bibr">16</xref>] for the prevention of skin aging, the reduction of fat deposition, or the promotion of tissue regeneration [<xref rid="B17-plants-14-02639" ref-type="bibr">17</xref>], while the European Medicines Agency [<xref rid="B18-plants-14-02639" ref-type="bibr">18</xref>] recommends the use of the vegetal product for minor venous circulatory disturbances (orally) or for minor inflammation of the skin and feelings of heaviness in the legs (topically). The European Pharmacopoeia mentions a minimum content 0.3% of coumarin, which relates to the dried plant material [<xref rid="B19-plants-14-02639" ref-type="bibr">19</xref>]. The phytochemical profile of <italic toggle="yes">M. officinalis</italic> consists mainly of cinnamic acid, melilotoside, coumarin, melilotin, scopoletin, umbelliferone, kaempferol, and quercetin glycosides [<xref rid="B10-plants-14-02639" ref-type="bibr">10</xref>,<xref rid="B11-plants-14-02639" ref-type="bibr">11</xref>,<xref rid="B17-plants-14-02639" ref-type="bibr">17</xref>].</p><p><italic toggle="yes">M. albus</italic> is another <italic toggle="yes">Melilotus</italic> species that is relatively abundant among Romanian spontaneous Flora. It is a herbaceous biennial plant with white flowers and is considered very important for honey production. A few studies have noted the main active compounds as being the coumarins, flavonoids, and tannins from the aerial parts [<xref rid="B20-plants-14-02639" ref-type="bibr">20</xref>]; as well as their use as anticoagulants, to treat external ulcers in traditional medicine, or as antimicrobial and antibiofilm agents [<xref rid="B12-plants-14-02639" ref-type="bibr">12</xref>].</p><p>Because the content of bioactive compounds can vary due to their role in plant defence mechanisms (in response to various stressors) and the pedoclimatic conditions of the area of harvest, the use of a standardized extract is essential for determining therapeutic efficacy and limiting secondary reactions [<xref rid="B21-plants-14-02639" ref-type="bibr">21</xref>]. Taking into account the growing interest in the therapeutic potential of plant extracts and the well-documented cardioprotective activity of several major compounds (vanillic and protocatechuic acids) [<xref rid="B22-plants-14-02639" ref-type="bibr">22</xref>,<xref rid="B23-plants-14-02639" ref-type="bibr">23</xref>,<xref rid="B24-plants-14-02639" ref-type="bibr">24</xref>,<xref rid="B25-plants-14-02639" ref-type="bibr">25</xref>], but also the gap in the available literature concerning the evaluation of the cardioprotective properties of <italic toggle="yes">Melilotus</italic> species and the evaluation of bioactive compounds from plant material harvested from Romania, we propose to investigate the cardioprotective effects of several <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> samples from different areas.</p><p>Therefore, the aim of our research is to determine the phytochemical composition of <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> aerial parts collected from Romania and to evaluate their in vivo and in vitro antioxidant effects, as well as the cardioprotective potential of standardized extracts, in order to enhance the therapeutic value of herbal medicines and to justify their use based on scientific evidence. To the best of our knowledge, this is the first in vivo evaluation of the cardioprotective effects of <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. Albus</italic>; thus, our study is the first to demonstrate the valuable properties of these extracts in herbal remedies.</p></sec><sec id="sec2-plants-14-02639"><title>2. Materials and Methods</title><sec id="sec2dot1-plants-14-02639"><title>2.1. Chemicals and Reagents</title><p>In the LC-MS/MS phytochemical analysis, 25 polyphenolic standards were utilized. Analytical standards, including caftaric acid, chlorogenic acid, caffeic acid, p-coumaric acid, rutin, apigenin, kaempferol, luteolin, gentisic acid, myricetol, fisetin, (+)-catechin, (&#8722;)-epicatechin, quercetin, quercitrin, isoquercitrin, hyperoside, patuletin, protocatechuic acid, syringic acid, vanillic acid, and rosmarinic acid, with purity levels ranging from 78% to 98%, were purchased from Sigma-Aldrich Chemie GmbH, Schnelldorf, Germany. Gallic acid, with a purity of 98%, was procured from Merck, Darmstadt, Germany. Additionally, ferulic acid and sinapic acid, both with &#8805;98% purity, were obtained from Roth, Karlsruhe, Germany. The solvents employed for extraction and separation included methanol, ammonium acetate, and acetonitrile of HPLC analytical-grade, and petroleum ether, chloroform, hydrochloric acid, acetic acid, and potassium hydroxide of analytical-grade [<xref rid="B26-plants-14-02639" ref-type="bibr">26</xref>,<xref rid="B27-plants-14-02639" ref-type="bibr">27</xref>].</p><p>These solvents and Folin&#8211;Cioc&#226;lteu reagent were purchased from Merck (Darmstadt, Germany). 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) were purchased from Alfa-Aesar (Karlsruhe, Germany). Sodium carbonate, sodium acetate trihydrate, anhydrous aluminium chloride, coumarin, lead (II) acetate, 2,4,6-tri(2-pyridyl)-1,3,5-triazine (TPTZ) reagent, 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) reagent, Trolox, and isoprenaline were obtained from Sigma-Aldrich (Schnelldorf, Germany). The commercial biochemistry kits for the pharmacological investigations (kit CK-MB-LQ. Anti CK-M. Immunoinh.; kit GOT/AST-LQ. IFCC. Enzymatic&#8211;UV; GPT/ALT-LQ. IFCC. Enzymatic&#8211;UV; kit UREA-LQ. Urease-GLDH. Kinetic; kit creatinine-J. J) were obtained from S.C. DG Diagnostics S.R.L. Cluj-Napoca [<xref rid="B3-plants-14-02639" ref-type="bibr">3</xref>,<xref rid="B26-plants-14-02639" ref-type="bibr">26</xref>].</p></sec><sec id="sec2dot2-plants-14-02639"><title>2.2. Plant Material</title><p><italic toggle="yes">Melilotus officinalis</italic> and <italic toggle="yes">M. albus</italic> aerial parts were harvested from wild populations during the flowering stage from different locations chosen through random selection. The voucher specimens were deposited in the Herbarium of the Pharmacognosy Department, University of Medicine and Pharmacy, Cluj-Napoca, as presented in <xref rid="plants-14-02639-t001" ref-type="table">Table 1</xref>. The plant material was authenticated by A.-M.V. in the Department of Pharmaceutical Botany. Each plant material was air-dried at room temperature, ground to a fine powder with an electric grinder, and used for extraction.</p></sec><sec id="sec2dot3-plants-14-02639"><title>2.3. Preparation of Plant Extracts</title><p>The extraction of aerial parts from <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> was performed on a water bath at 60 &#176;C for 50 min with a 1:10 ratio of sample (<italic toggle="yes">m</italic>/<italic toggle="yes">v</italic>) to 70% ethanol (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>), followed by ultrasonic-assisted extraction for 50 min [<xref rid="B28-plants-14-02639" ref-type="bibr">28</xref>]. The obtained extracts were concentrated to dryness under reduced pressure at 40 &#176;C. The dried extracts were stored at 4 &#176;C until further analysis. The extracts yields were expressed in relation to the dry weight of the vegetal product (mg crude extract/g dry weight plant material). The polyphenolic compounds remained stable at 4 &#176;C over the four-week storage period, with no significant decrease observed in their total content or antioxidant activity. It should be noted, however, that long-term stability may differ depending on the specific polyphenol class, the sample matrix, and exposure to environmental factors such as light or oxygen, which were controlled in the present study.</p></sec><sec id="sec2dot4-plants-14-02639"><title>2.4. Quantitative Analyses of Total Bioactive Compounds</title><p>The total phenolic content (TPC) of the ethanol extracts from <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> aerial parts was determined by the Folin&#8211;Cioc&#226;lteu method, as detailed previously [<xref rid="B29-plants-14-02639" ref-type="bibr">29</xref>]. The total phenolic content was expressed as mg gallic acid equivalents (GAEs)/g dry extract. The experiments were performed in triplicate.</p><p>The evaluation of the total flavonoid content (TFC) of the extracts from <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> was performed using a spectrophotometric method [<xref rid="B30-plants-14-02639" ref-type="bibr">30</xref>]. The flavonoids content was expressed as rutin equivalents (mg REs)/g dry extract. The experiments were performed in triplicate.</p><p>The total coumarin content (TCC) of the extracts from <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> was determined using the spectrophotometric method with a JASCO UV-VIS spectrophotometer. Briefly, this Borntrager reaction is based on the solubility of free coumarin derivatives in polar organic solvents and the solubility of their soluble alkali phenolates. The ionization of phenolic hydroxyls in the molecule by alkaline hydroxide causes a bathochromic deviation of 320 nm, which is proportional to the coumarin concentration. TCC was expressed as mg coumarin/g dry extract (mg CE/g dry extract). The experiments were performed in triplicate [<xref rid="B31-plants-14-02639" ref-type="bibr">31</xref>].</p></sec><sec id="sec2dot5-plants-14-02639"><title>2.5. LC-MS/MS Analysis of Polyphenols Apparatus and Chromatographic Conditions</title><p>The ethanol extracts of <italic toggle="yes">Melilotus</italic> species were analyzed for their phytochemical composition using liquid chromatography&#8211;tandem mass spectrometry (LC-MS/MS). The instrument used was an Agilent 1100 HPLC Series system, equipped with an autosampler, binary gradient pump, degasser, and a column thermostat maintained at 48 &#176;C, along with a UV detector. The mass spectrometric analysis was performed using an Agilent Ion Trap 1100 SL, featuring both electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI) sources. The system operated at a flow rate of 1 mL/min and an injection volume of 5 &#181;L, using a Zorbax SB-C18 reverse-phase analytical column for compound separation.</p><p>Rosmarinic acid identification and quantification involved a mobile phase comprising acetonitrile and 1 mM ammonium acetate in water. A gradient elution began with 5% acetonitrile, increasing to 25% at 3.3 min (method a). The MS operated in negative ionization mode with ESI, targeting the fragmentation and isolation of the deprotonated rosmarinic acid molecule (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 359).</p><p>For the remaining 24 polyphenolic compounds, two separate analytical methods were employed. The first method focused on 18 polyphenols, using a mobile phase of methanol and 0.1% acetic acid. The elution process utilized a binary gradient, starting with 5% methanol and reaching 42% at 35 min, followed by a 3 min isocratic elution. Detection was carried out using both UV and MS modes, with the UV detector set at 330 nm for polyphenolic acids and 370 nm for flavonoids and their aglycones. The MS conditions included a negative ionization mode with an electrospray ion source. The specific mass spectra signal for each compound was used for identification, while UV and MS assisted in quantification. A standard polyphenol solution was used to create a spectral library, with detection limits determined based on a signal-to-noise ratio greater than 3 (method b).</p><p>The second LC-MS method was applied to six polyphenols, with working conditions similar to those of method b, but with a different mobile phase gradient. In this case, the gradient commenced with 3% methanol, increased to 8% methanol at 3 min, and then to 20% methanol from 8.5 min to 10 min. Identification and quantification for these compounds were performed exclusively in the MS mode, under previously described conditions (method c).</p><p>Chromatographic data were collected and processed using DataAnalysis (v5.3) and ChemStation software (vB01.03) from Agilent Inc. The retention times of the compounds were established using reference standards and confirmed through mass spectrometry. Sample spiking with 10 &#181;g/mL polyphenol solution ensured accuracy. Compound identification was based on comparing retention times and ESI-MS spectra with those of standards under identical conditions. Quantification of polyphenols in each extract employed the external standard method, with calibration curves linear in the range of 0.5&#8211;50 &#181;g/mL (R<sup>2</sup> &gt; 0.999) [<xref rid="B26-plants-14-02639" ref-type="bibr">26</xref>].</p></sec><sec id="sec2dot6-plants-14-02639"><title>2.6. The Evaluation of In Vitro Antioxidant Potential</title><p>The evaluation of the radical scavenging effect of the ethanol extracts from <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> aerial parts was achieved by DPPH and FRAP radical scavenging assays, and more detail can be found in [<xref rid="B30-plants-14-02639" ref-type="bibr">30</xref>]. The reference standard was Trolox. The antioxidant potential was expressed as IC<sub>50</sub> (&#956;g TE/mL) for the DPPH assay and as Trolox equivalents (TEs)/100 mL of extract for the FRAP method. All determinations were performed in triplicate.</p></sec><sec id="sec2dot7-plants-14-02639"><title>2.7. The Evaluation of In Vivo Cardioprotective Effects</title><sec id="sec2dot7dot1-plants-14-02639"><title>2.7.1. Experimental Protocol</title><p>The in vivo experiments were performed on adult male Wistar albino rats (weigh 200&#8211;250 g) from the &#8220;Iuliu Ha&#539;ieganu&#8221; University of Medicine and Pharmacy Animal Facility. Prior to and during the experiments, animals had ad libitum access to water and free access to standard pellets-based diet (Cantacuzino Institute, Bucharest, Romania) and were housed in proper conditions (12 h night/day cycle, temperatures of 21&#8211;22 &#176;C, and humidity of 50&#8211;55%). All treatments that involved animals were in accordance with EU Directive 2010/63/EU on the protection of animals used for scientific purposes and guidelines for Animal Welfare. The experimental design of animal study was approved by the Institutional Animal Ethical Committee (IAEC) of the &#8220;Iuliu Ha&#539;ieganu&#8221; University of Medicine and Pharmacy Cluj-Napoca and by the National Sanitary Veterinary and Food Safety Agency (no. 382/94).</p><p>The experimental groups were organized by simple random allocation, and the treatments were administered each day at the same hour in order to minimize potential confounding factors.</p></sec><sec id="sec2dot7dot2-plants-14-02639"><title>2.7.2. Experimental Myocardial Ischemia</title><p>For the evaluation of the cardioprotective potential of <italic toggle="yes">Melilotus officinalis</italic> and <italic toggle="yes">M. albus</italic> aerial parts, the animals were divided randomly into five groups (n = 5). Group 1&#8212;negative control (CONTROL); Group 2&#8212;isoprenaline (ISO); Group 3&#8212;<italic toggle="yes">Melilotus officinalis</italic> extract (MO2); Group 4&#8212;<italic toggle="yes">Melilotus albus</italic> extract (MA2); and Group 5&#8212;positive control coumarin (CUM). The animals received the following: (1) CONTROL&#8212;0.9% saline solution by gavage 1 mL/day for 7 days; (2) ISO&#8212;0.9% saline solution by gavage 1 mL/day for 7 days; (3) MO2&#8212;<italic toggle="yes">Melilotus officinalis</italic> extract 10% in distilled water (<italic toggle="yes">m</italic>/<italic toggle="yes">V</italic>) by gavage 1 mL/day for 7 days; (4) MA2&#8212;<italic toggle="yes">Melilotus albus</italic> extract 10% in distilled water (<italic toggle="yes">m</italic>/<italic toggle="yes">V</italic>) by gavage 1 mL/day for 7 days; (5) CUM&#8212;coumarin solution by gavage 25 mg/kg BW, for 7 days. The animals from groups (2)&#8211;(5) received isoprenaline subcutaneously 150 mg/kg BW on days 8 and 9 in order to induce MI [<xref rid="B3-plants-14-02639" ref-type="bibr">3</xref>,<xref rid="B32-plants-14-02639" ref-type="bibr">32</xref>]. The electrocardiogram (ECG) was recorded on days 2, 7, and 10. On day 10, after ECG registration, blood samples from animals were collected under general anaesthesia (induced by 70 mg ketamine/kg BW and 10 mg xylasine/kg BW) for the estimation of cardiac markers and oxidative stress markers [<xref rid="B33-plants-14-02639" ref-type="bibr">33</xref>]. The samples were stored at &#8722;80 &#176;C until further analysis, and cardiac markers GOT, GPT, and CK-MB were evaluated using commercial kits.</p></sec><sec id="sec2dot7dot3-plants-14-02639"><title>2.7.3. Electrocardiography Results</title><p>In several cardiac abnormalities, such as myocardial infarction or myocardial ischemia, changes in the normal ECG pattern may appear. Therefore, in order to evaluate the effects of the extracts on the heart&#8217;s electrical activity, the ECGs were recorded. The overnight-fasted rats were anesthetized with 60 mg ketamine/kg BW and 8 mg xylazine /kg BW (<italic toggle="yes">intraperitoneal administration</italic>). At 15 min after anaesthesia, animals were placed in the supine position on a board, electrodes were bound on the paw pads of each rat, and ECG was recorded from the limb lead at position II (right forelimb to left hind limb) with a Biopac MP150 system. The ECG apparatus was calibrated at 1 mV/1 cm with a speed of 50 mm/s. Analysis of ECG waves was conducted as previously described [<xref rid="B34-plants-14-02639" ref-type="bibr">34</xref>]. Briefly, heart rate (beats/min), RR intervals (ms), QT interval (ms), and ST segment changes (mV) were calculated. The corrected QT interval (QTc), which is used to rectify the influence of the heart rate on the QT interval, was also calculated according to Bazett&#8217;s formula [<xref rid="B35-plants-14-02639" ref-type="bibr">35</xref>].</p></sec><sec id="sec2dot7dot4-plants-14-02639"><title>2.7.4. The Evaluation of In Vivo Antioxidant Properties</title><p>The total oxidative status (TOS) of the serum was measured as previously reported, using a colorimetric method with hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) as standard. In the presence of different oxidant species, a ferrous ion is oxidated into a ferric ion, and the absorbance is measured using a spectrophotometer. The results were presented in &#181;mol H<sub>2</sub>O<sub>2</sub> equivalents/L [<xref rid="B36-plants-14-02639" ref-type="bibr">36</xref>]. The total antioxidant capacity (TAC) was determined as previously reported, using Trolox as standard [<xref rid="B37-plants-14-02639" ref-type="bibr">37</xref>]. The oxidative stress index (OSI) represents an indicator of the degree of oxidative stress and is calculated as the ratio of the TOS (&#956;mol H<sub>2</sub>O<sub>2</sub> Equiv/L) to the TAC (mmol Trolox Equiv/L) [<xref rid="B38-plants-14-02639" ref-type="bibr">38</xref>,<xref rid="B39-plants-14-02639" ref-type="bibr">39</xref>]. Malondialdehyde (MDA) was evaluated as a lipid peroxidation marker using thiobarbituric acid, as previously reported, with 1,1,3,3-tetraethoxypropane as standard, and was expressed as &#956;M/L [<xref rid="B40-plants-14-02639" ref-type="bibr">40</xref>]. Total thiols (SH) were estimated using Ellman&#8217;s reagent, as previously mentioned, with glutathione (GSH) as standard, and were expressed as &#956;M GSH/L [<xref rid="B41-plants-14-02639" ref-type="bibr">41</xref>]. Initially, serum proteins were removed [<xref rid="B42-plants-14-02639" ref-type="bibr">42</xref>]; then, the serum NO concentration was determined using the Griess reaction and a sodium nitrite-based curve and expressed as nitrite &#956;mol/L [<xref rid="B43-plants-14-02639" ref-type="bibr">43</xref>]. All spectrophotometric measurements were performed using a Jasco V-530 UV-Vis spectrophotometer (Jasco International Co., Ltd., Tokyo, Japan).</p></sec></sec><sec id="sec2dot8-plants-14-02639"><title>2.8. Multivariate Analysis</title><p>Multivariate analysis of data was accomplished using principal component analysis (PCA). PCA was implemented to assess the effect of species type and harvesting region on the quality of extracts, particularly the phytochemical composition. Variables, including TFC, TPC, TCC, DPPH, and FRAP, were scaled to unit variance, and biplots were generated for the interpretation of the model.</p><p>Orthogonal projections to latent structures-based discriminant analysis (OPLS-DA) were applied to investigate the treatment-induced differences in the expression profile of the oxidative stress parameters and cardiac markers. The X dataset (variables) and the Y dataset (class membership dummy variables) were scaled to unit variance before model development. Model performance was evaluated by considering the fraction of explained variability (R2X, R2Y) and the predictive capacity (Q2). Separate models were developed between an applied treatment and the negative control. The p(corr) vectors of two OPLS-DA models were represented (SUS plots) to highlight the shared and unique contribution of the applied treatments with respect to the investigated variables. The vertical axis of SUS figures plots the correlation vector of the model that discriminates positive (ISO) and negative control, while the horizontal axis refers to the comparison of another treatment and negative control (<xref rid="plants-14-02639-f001" ref-type="fig">Figure 1</xref>).</p><p>Shared effects are identified through variables displayed on diagonal A, where both treatments lead to an increase (positive) or a decrease (negative) in the variables. Opposite effects can be identified through variables placed on diagonal B, while unique effects are associated with regions 1&#8211;2&#8211;3&#8211;4. In case of unique effects, the variable has a high absolute value on only one axis [<xref rid="B44-plants-14-02639" ref-type="bibr">44</xref>,<xref rid="B45-plants-14-02639" ref-type="bibr">45</xref>].</p></sec><sec id="sec2dot9-plants-14-02639"><title>2.9. Statistical Analysis</title><p>The analyses were performed in triplicate, and the obtained results were expressed as means &#177; standard deviation (SD). Data were compared using one-way ANOVA and post hoc Bonferroni&#8211;Holm test. Pearson&#8217;s correlation coefficient (<italic toggle="yes">r</italic>) was used to evaluate relationships between parameters of the same group. The statistical significance of differences between data was evaluated by SPSS 20.0 for Windows (SPSS Inc., Chicago, IL, USA). The level of significance was established at <italic toggle="yes">p</italic> &lt; 0.05.</p></sec></sec><sec sec-type="results" id="sec3-plants-14-02639"><title>3. Results and Discussion</title><sec id="sec3dot1-plants-14-02639"><title>3.1. Quantitative Analyses of Total Bioactive Compounds</title><p>The quantitative determinations of the main active compounds from the <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> aerial parts extracts are presented (<xref rid="plants-14-02639-t002" ref-type="table">Table 2</xref>). <italic toggle="yes">M. officinalis</italic> from the Brasov county (MO2) extract contains higher quantities of active constituens than one from Cluj county (MO1). Regarding other extracts, there are small differences between the <italic toggle="yes">Melilotus albus</italic> extract from Alba county (MA2) and the one from Cluj county (MA1). The amount of TPC from MO2 is higher than that from MA2 (138.157 mg GAE/g versus 127.279 mg GAE/g), and the same trend was observed regarding the total coumarins (47.691 mg CE/g, and, respectively, 37.331 mg CE/g), while for total flavonoids, it was reversed (78.201 mg RE/g versus 86.105 mg RE/g).</p><p>Our results are in accordance with those published by other researchers. For instance, Ayadi et al. determined the total polyphenols in ethanol extracts from <italic toggle="yes">M. officinalis</italic> aerial parts from Morocco, and their quantity increased from 2.14% at the vegetative stage to 2.37% at the flowering stage, while between some ecotypes, the level was found to be between 2.01% and 2.69% [<xref rid="B46-plants-14-02639" ref-type="bibr">46</xref>]. In another research from 2020, Szymanski et al. found 2.101% to 2.438% total polyphenols and 0.748% to 0.975% total flavonoids in <italic toggle="yes">M. officinalis</italic> water extracts, whilst <italic toggle="yes">M. alba</italic> aerial parts were found to contain a higher amount of polyphenols (2.7&#8211;3.5%) and flavonoids (0.8&#8211;1.1%) [<xref rid="B47-plants-14-02639" ref-type="bibr">47</xref>]. Another study on <italic toggle="yes">M. indicus</italic> showed that aqueous extracts contain a higher quantity of total polyphenols (144.382 &#181;g GAE/ mg extract) and flavonoids (25.65 &#181;g QE/ mg) than ethanol extracts (120.067 &#181;g GAE/mg extract; flavonoids: 26.375 &#181;g QE/mg) [<xref rid="B48-plants-14-02639" ref-type="bibr">48</xref>].</p><p>The differences between the results could be explained by different extraction techniques, the solvent used, other variable extraction parameters, or the manner of reporting the results. Thus, the research on <italic toggle="yes">M. officinalis</italic> flowers from Iran presents values between 48.21 and62.4 mg QUE/g for flavonoids, while the total phenolic content has values between 24.32 and 38.08 mg GAE/g [<xref rid="B49-plants-14-02639" ref-type="bibr">49</xref>].</p><p>Previous research on the coumarin content of <italic toggle="yes">Melilotus</italic> sp. aerial parts grown in South Australia showed that it can range from 0.06 to 0.75%, and the variations are determined by extraction procedures and solvents, as well as the plant species. <italic toggle="yes">M. officinalis</italic> contains 0.332% coumarins (between 0.09 and 0.61%) and <italic toggle="yes">M. albus</italic> 0.523% (between 0.06 and 1.3%) [<xref rid="B50-plants-14-02639" ref-type="bibr">50</xref>]. The authors mention the importance of evaluating the coumarin content in each sample since there are significant differences between them, and the biological activities might be influenced.</p><p>The variation in polyphenol quantities in different plant samples could be determined by genetic or ecological factors or the status of secondary metabolites in various growing locations, as previously shown [<xref rid="B51-plants-14-02639" ref-type="bibr">51</xref>].</p><p>Due to the results obtained from the evaluation of total bioactive compounds, for further research, the plant materials MO2 (<italic toggle="yes">M. officinalis</italic> from Brasov County) and MA2 (<italic toggle="yes">M. alba</italic> from Alba County) were chosen for additional investigations.</p></sec><sec id="sec3dot2-plants-14-02639"><title>3.2. LC-MS/MS Analysis of Polyphenols</title><p>The phytochemical analysis of <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> extracts was performed using a targeted LC-MS/MS technique for the identification and quantification of several poyphenolic compounds, namely, flavonoids and phenolic acids, and the results are presented in <xref rid="plants-14-02639-t003" ref-type="table">Table 3</xref>.</p><p>Chlorogenic, ferulic, protocatechuic, vanillic, syringic, and rosmarinic acids, as well as catechin, were found in higher quantities in the <italic toggle="yes">M. officinalis</italic> extract, with vanillic acid (57.37 &#177; 2.36 mg/100 g extract) and protocatechuic acid (40.64 &#177; 3.51) being the main compounds. Chlorogenic and gallic acids were determined only in <italic toggle="yes">M. officinalis</italic> extracts, as well as caftaric acid, which was found in small quantities (&lt;LOQ). <italic toggle="yes">p</italic>-Coumaric acid was identified in both extracts, but the content is below the limit of detection.</p><p>The major compound of both investigated extracts, vanillic acid, is a monohydroxybenzoic acid found in numerous medicinal plants. Several recent studies showed the antioxidant properties, as well as its anti-inflammatory, antidiabetes, and antiallergic effects of this compound, which are related to the reduction in lymphocytes, neutrophils, eosinophils, and macrophage levels, the reduction in TNF-&#945;, IgE, IL-4, and IL-5 levels, and the increasing IFN-&#947; levels in serum [<xref rid="B52-plants-14-02639" ref-type="bibr">52</xref>].</p><p>Another recent study by Magiera et al. demonstrated the antioxidant and anti-inflammatory properties for vanillic acid in human neutrophils and plasma, as well as in vitro on non-cellular models [<xref rid="B53-plants-14-02639" ref-type="bibr">53</xref>].</p><p>Protocatechuic acid is another phenolic compound identified in both <italic toggle="yes">Melilotus</italic> sp. extracts, with high quantity in <italic toggle="yes">M. officinalis</italic> aerial parts. Protocatechuic acid has recently been the subject of several studies, which revealed its important therapeutic effects; it has neuroprotective, anticancer, analgesic, anti-inflammatory, antihyperglycemic, and antioxidant properties, which are useful both in the prevention and treatment of several diseases [<xref rid="B54-plants-14-02639" ref-type="bibr">54</xref>]. Other studies found that it has chemopreventive potential due to its inhibition of in vitro chemical carcinogenesis, and it exerts pro-apoptotic and anti-proliferative effects in different tissues [<xref rid="B55-plants-14-02639" ref-type="bibr">55</xref>].</p><p>The results obtained in this study are in line with those of other authors on some polyphenols from <italic toggle="yes">Melilotus</italic> species. Higher quantities of <italic toggle="yes">o</italic>- and <italic toggle="yes">p</italic>-coumaric acids were determined in dried flowers compared with fresh ones. The content in <italic toggle="yes">o</italic>-coumaric acid was 1.00 mg/g in <italic toggle="yes">M. officinalis</italic> and 0.34 mg/g in <italic toggle="yes">M. albus</italic> dried samples, while in the fresh ones, it was below LOQ. <italic toggle="yes">p</italic>-Coumaric acid content was 0.16 mg/g in <italic toggle="yes">M. albus</italic> dry flowers and 0.13 mg/g in fresh ones; while in <italic toggle="yes">M. officinalis</italic>, it was 0.12 mg/g and 0.07 mg/g, respectively [<xref rid="B56-plants-14-02639" ref-type="bibr">56</xref>].</p><p>The important qualitative and quantitative differences between <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> aerial parts allow for a better correlation between the chemical composition and pharmacological properties of the extracts and justify the use of standardized extracts for the in vivo evaluation of plant extracts&#8217; biological properties.</p><p>Compared to other polyphenol-rich foods, the plants investigated in this study demonstrate a distinct phytochemical profile, characterized not only by high total polyphenol content but also by unique combinations of specific bioactive compounds, including phenolic acids, flavonoids, and coumarins not commonly found in widely consumed sources. This compositional uniqueness may underlie the observed in vivo cardioprotective and antioxidant effects, which have not been previously reported for <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> extracts. Furthermore, the potential synergistic interactions between these compounds could confer enhanced biological activity, positioning these plants as promising candidates for the development of novel functional foods or nutraceuticals with targeted health benefits.</p></sec><sec id="sec3dot3-plants-14-02639"><title>3.3. In Vitro Antioxidant Properties</title><p>The results of the evaluation of antiradical properties of <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> extracts are presented (<xref rid="plants-14-02639-t004" ref-type="table">Table 4</xref>). The ethanol extracts of <italic toggle="yes">M. officinalis</italic> aerial parts with higher total polyphenolic content had a better antioxidant effect in the DPPH test (IC<sub>50</sub> = 92.19 &#956;g TE/mL and 118.03 &#956;g TE/mL, respectively). The same tendency was observed for <italic toggle="yes">M. albus</italic> extracts (IC<sub>50</sub> = 52.19 &#956;g TE/mL and 73.25 &#956;g TE/mL, respectively). Another study found values of DPPH scavenging activity 9.0 &#956;g/mL for hexane extract, 35.6 &#956;g/mL for 96% ethanol extract, and 30.2 &#956;g/mL for 50% ethanol extract of <italic toggle="yes">M. officinalis</italic> [<xref rid="B57-plants-14-02639" ref-type="bibr">57</xref>]. The results cannot be directly compared with those of the present study since they were expressed as the % inhibition. Other authors showed that in <italic toggle="yes">M. alba</italic>, the higher content of polyphenols (3.01%) correlated with the lower antioxidant activity of water extracts (IC<sub>50</sub> = 5.31 mg/mL) when compared with <italic toggle="yes">M. officinalis</italic>, with 2.43% polyphenols and IC<sub>50</sub> = 4.35 mg/mL [<xref rid="B47-plants-14-02639" ref-type="bibr">47</xref>]. The authors revealed variability in the antioxidant activity, which depends on the extract concentration as well as the solvent used.</p><p>Another recent study by Sowa et al. on the antioxidant properties of <italic toggle="yes">Melilotus</italic> sp. found a higher antioxidant effect in leaf extracts when compared with flower extracts in DPPH and FRAP tests: for <italic toggle="yes">M. albus</italic> flower extract, 49.18 &#181;mol TE/g (DPPH test) and 53.77 &#181;mol TE/g (FRAP test); for <italic toggle="yes">M. officinalis</italic> flower extract, 73.26 &#181;mol TE/g and 82.72 &#181;mol TE/g, respectively [<xref rid="B56-plants-14-02639" ref-type="bibr">56</xref>]. A comparison with the present study is not possible since these differences might be due to the distinct extraction method and plant organ evaluated, as well as the manner in which the results are presented and the differences in methodology.</p></sec><sec id="sec3dot4-plants-14-02639"><title>3.4. Evaluation of In Vivo Cardioprotective Activity</title><p>The cardioprotective effects of <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> were determined in vivo using a rat model of isoprenaline-induced acute myocardial infarction. The therapeutic efficacy was evaluated by analyzing oxidative stress markers (OSI, TAC, MDA, NO<sub>x</sub>, SH, and TOS), along with the biochemical indicators characteristic of myocardial injury (GOT, GPT, and CK-MB) (<xref rid="plants-14-02639-t005" ref-type="table">Table 5</xref>).</p><p>Myocardial infarction induction led to significant increases in serum GOT and GPT levels (<italic toggle="yes">p</italic> &lt; 0.01) and CK-MB levels (<italic toggle="yes">p</italic> &lt; 0.001) when compared to the control group. This was accompanied by a pronounced oxidative imbalance, evidenced by elevated TOS, OSI (<italic toggle="yes">p</italic> &lt; 0.001), and NO<sub>x</sub> levels (<italic toggle="yes">p</italic> &lt; 0.05), along with a significant reduction in SH levels (<italic toggle="yes">p</italic> &lt; 0.01).</p><p>Relative to the isoprenaline group, pretreatment with the MA2 extract significantly reduced TOS and OSI levels (<italic toggle="yes">p</italic> &lt; 0.001). CUM produced a small increase (<italic toggle="yes">p</italic> &lt; 0.05), whereas MO2 showed no statistically significant effect (<italic toggle="yes">p</italic> &gt; 0.05). CUM pretreatment led to a highly significant increase in TAC levels (<italic toggle="yes">p</italic> &lt; 0.01), while MO2 and MA2 elicited moderate yet significant improvements on this parameter (<italic toggle="yes">p</italic> &lt; 0.05).</p><p>Regarding lipid peroxidation, MO2 and MA2 markedly lowered MDA levels (<italic toggle="yes">p</italic> &lt; 0.001), with CUM having a milder but still significant effect (<italic toggle="yes">p</italic> &lt; 0.01). A significant reduction in NO<sub>x</sub> concentrations was observed with MO2 (<italic toggle="yes">p</italic> &lt; 0.05) and MA2 (<italic toggle="yes">p</italic> &lt; 0.01), while CUM did not influence this parameter. MA2 extract significantly increased SH levels, with the most pronounced effect observed for MO2 and CUM (<italic toggle="yes">p</italic> &lt; 0.001), whilst MA2 produced a moderate but significant response (<italic toggle="yes">p</italic> &lt; 0.05).</p><p>Taking into account the myocardial injury markers, MA2 significantly reduced GOT (<italic toggle="yes">p</italic> &lt; 0.01), GPT levels (<italic toggle="yes">p</italic> &lt; 0.001), and CK-MB (<italic toggle="yes">p</italic> &lt; 0.001); MO2 extract and CUM did not produce statistically significant changes in GOT and GPT parameters (<italic toggle="yes">p</italic> &gt; 0.05), whilst CK-MB was significantly reduced by MO2 and CUM (<italic toggle="yes">p</italic> &lt; 0.001) (<xref rid="plants-14-02639-t006" ref-type="table">Table 6</xref>).</p><p>ECG recording from days 1 and 7 showed no significant changes in all groups. The ECG patterns of normal- and experimental-group rats on day 10 are shown in <xref rid="plants-14-02639-t007" ref-type="table">Table 7</xref>. Isoprenaline administration resulted in notable ECG alterations, including a reduced RR interval and increased heart rate (HR), QT, and corrected QT (QTc) intervals. PR, QRS, and ST were insignificantly changed by isoprenaline-induced infarct-like lesion. RR was increased by the pretreatment with MO2 (<italic toggle="yes">p</italic> &lt; 0.01), MA2 (<italic toggle="yes">p</italic> &lt; 0.5), and CUM (<italic toggle="yes">p</italic> &lt; 0.001). HR was significantly reduced by MO2, MA2, and CUM (<italic toggle="yes">p</italic> &lt; 0.001); QT was moderately yet significantly reduced by MO2 (<italic toggle="yes">p</italic> &lt; 0.05) and CUM (<italic toggle="yes">p</italic> &lt; 0.001); and QTc was decreased significantly only by CUM (<italic toggle="yes">p</italic> &lt; 0.001).</p><p>When comparing the two extracts, both MO2 and MA2 exhibited significant antioxidant and cardioprotective effects, with some variation in their activity profiles. MO2 and MA2 significantly reduced oxidative stress markers such as MDA, TOS, and OSI and enhanced antioxidant defenses (TAC and SH). However, MA2 demonstrated slightly greater efficacy in decreasing OSI and reducing NO levels&#8212;a change not observed with CUM (<italic toggle="yes">p</italic> &gt; 0.05).</p><p>With respect to cardiac injury markers, both MO2 and MA2 significantly decreased GOT, GPT, and CK-MB levels, though MA2 exerted a slightly stronger effect on all markers.</p><p>Isoprenaline (ISO) is a synthetic catecholamine with toxic effect on the myocardium. The generation of ROS via the auto-oxidation of catecholamines, increased lipolysis, and the peroxidation of endogenous lipids are considered the main causative factors of isoprenaline-induced cardiac damage. The isoprenaline-induced MI increases cAMP formation due to an enhancement in adenylate cyclase activity; therefore, it leads to a higher lipid accumulation in the myocardium [<xref rid="B1-plants-14-02639" ref-type="bibr">1</xref>,<xref rid="B3-plants-14-02639" ref-type="bibr">3</xref>]. The rat model of ISO-induced MI is a well-accepted standardized model by which to determine the effects of several synthetic and natural cardioprotective agents, as well as the cardiac dysfunctions [<xref rid="B1-plants-14-02639" ref-type="bibr">1</xref>,<xref rid="B4-plants-14-02639" ref-type="bibr">4</xref>]. The biochemical, electrocardiographic, and histological modifications closely imitate that observed in acute MI and is considered a relevant model. Several natural products, extracts, and single- or polyherbal formulations are employed in traditional medicines for the treatment of ischemic heart diseases, showing major benefits due to their antioxidant and/or anti-inflammatory effects [<xref rid="B4-plants-14-02639" ref-type="bibr">4</xref>].</p><p>In this isoprenaline-induced myocardial infarction model, Trolox served as the positive control due to its well-documented antioxidant properties [<xref rid="B58-plants-14-02639" ref-type="bibr">58</xref>]. Trolox administration resulted in significant improvements in oxidative stress parameters, including reductions in NO levels (<italic toggle="yes">p</italic> &lt; 0.01), as well as TOS, OSI, and MDA levels (<italic toggle="yes">p</italic> &lt; 0.05). These effects were accompanied by significant increases in TAC and SH levels (<italic toggle="yes">p</italic> &lt; 0.01). Furthermore, Trolox exhibited cardioprotective activity, as evidenced by significantly reduced serum CK-MB levels (<italic toggle="yes">p</italic> &lt; 0.001) and GOT and GPT levels (<italic toggle="yes">p</italic> &lt; 0.05). These findings confirm the validity of the experimental model and establish a reference point for evaluating the cardioprotective potential of MO2 and MA2 extracts.</p><p>Several studies demonstrated the cardioprotective effects of vanillic acid&#8212;a phenolic compound identified in both <italic toggle="yes">Melilotus</italic> sp. extracts. There are several mechanisms involved in cardioprotection, such as the antioxidant effect by reducing oxidative stress and the progression of heart disease, the improving of cardiac function by increasing the NO levels and FRAP value and improving left ventricular function, and the anti-inflammatory effect via the reduction in pro-inflammatory cytokines and cardiac enzymes levels, such as GOT and CK-MB [<xref rid="B22-plants-14-02639" ref-type="bibr">22</xref>,<xref rid="B23-plants-14-02639" ref-type="bibr">23</xref>].</p><p>Another polyphenolic compound identified in both <italic toggle="yes">Melilotus</italic> sp. extracts is protocatechuic acid. Its cardioprotective effects have been proven in several studies, along with its anti-inflammatory (by reducing the levels of pro-inflammatory cytokines), anti-apoptotic (through the increase in the expression of anti-apoptotic proteins like B-cell lymphoma 2 and the decrease in the expression of pro-apoptotic proteins like Bax and caspase-3; therefore, it prevents cardiomyocyte loss and fibrosis), and antioxidant properties (by means of reducing the levels of oxidative stress markers like malondialdehyde while increasing the levels of antioxidant enzymes like glutathione, superoxide dismutase, and catalase in cardiac tissue) [<xref rid="B24-plants-14-02639" ref-type="bibr">24</xref>,<xref rid="B25-plants-14-02639" ref-type="bibr">25</xref>].</p><p>Another polyphenol present in <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> extracts is syringic acid. A number of studies have reported its potential as a therapeutic candidate for preventing and treating cardiovascular diseases, especially those associated with cardiac hypertrophy, fibrosis, and myocardial infarction. Syringic acid has been shown to mitigate isoproterenol-induced cardiac hypertrophy and fibrosis in vivo and in vitro, has demonstrated protective effects by reducing infarct size and improving erythrocyte morphology, and it also possesses antioxidant and anti-inflammatory properties. The downregulation of Ereg, the inhibition of apoptosis in cardiomyocytes, the modulation of inflammatory pathways like NF-&#954;B by scavenging free radicals and reducing oxidative stress, and the reduction of myocardial ischemia reperfusion injury by activating the PI3K/Akt/GSK-3&#946; signaling pathway are several prospective mechanisms of syringic acid [<xref rid="B59-plants-14-02639" ref-type="bibr">59</xref>,<xref rid="B60-plants-14-02639" ref-type="bibr">60</xref>,<xref rid="B61-plants-14-02639" ref-type="bibr">61</xref>].</p></sec><sec id="sec3dot5-plants-14-02639"><title>3.5. Multivariate Analysis</title><p>PCA was implemented to assess the effect of the harvest region and species type on the quality of the extracts, especially on the cardioprotective and in vivo antioxidant effects. Variables including DPPH, TFC, TPC, TCC, and FRAP were scaled to unit variance, and biplots were generated for the interpretation of the model.</p><list list-type="simple"><list-item><p>PART 1</p></list-item></list><p>The two PCs fitted on the obtained data explained 99.1% of the variability, enabling the identification of differences between the extracts (<xref rid="plants-14-02639-f002" ref-type="fig">Figure 2</xref>). The positioning of the observations (extracts) in the score plot suggested a larger variability between the two <italic toggle="yes">Melilotus officinalis</italic> samples compared to the <italic toggle="yes">Melilotus albus</italic>-based extracts. Overall, the replicates performed within each extract were highly reproducible. The MO1 samples showed larger DPPH and lower TCC-TPC-TFC values compared to MO2, whereas both <italic toggle="yes">M. officinalis</italic> showed lower FRAP than <italic toggle="yes">M. albus</italic>. The differences between the two <italic toggle="yes">M. albus</italic> extracts were reserved mostly to the FRAP, TCC, and DPPH variables. MA2 exhibited higher FRAP and lower TCC and DPPH than MA1. In a similar way, MA1 had higher FRAP and lower TCC and DPPH than MO2.
<list list-type="simple"><list-item><p>PART 2</p></list-item></list></p><p>SUS plots offer an easy visualization of the shared and unique effects exhibited by two different treatments compared to a control treatment. The shared effects can be identified by looking at the variables situated in the upper-right and lower-left corners. Thus, the administration of ISO (M4), CUM/ISO (M5), MO2/ISO (M6), or MA2/ISO (M7) led to an increase in the variables placed in the upper-right corner. The treatment with MA2/ISO had a lesser effect on GOT and GPT compared to MO2/ISO and CUM/ISO. The PR and RR variables, placed in the lower-left corner, suggested that the treatments with ISO, MO2/ISO, or MA2/ISO produced a negative effect, leading to a decrease (<xref rid="plants-14-02639-f003" ref-type="fig">Figure 3</xref>b,c). From <xref rid="plants-14-02639-f003" ref-type="fig">Figure 3</xref>a, the opposite effect was identified for the co-administration of CUM/ISO as it offered an increase in PR and RR.</p><p>A positive effect on CK-MB was identified only for the administration of ISO, whereas CUM/ISO (M5), MO2/ISO (M6), and MA2/ISO (M7) did not have an influence. Regarding the QRS-QTC-HR variable group, the administration of MO2/ISO, MA2/ISO, and ISO offered a positive effect compared to the control treatment, whereas the administration of CUM/ISO produced a negative effect.</p><p>Apart from MA2/ISO, exposure to ISO, CUM/ISO, and MO2/ISO produced an increase in ST.</p><p>Compared to the control treatment, exposure to ISO was not significant for TAC, whereas the use of MO2/ISO, MA2/ISO, and CUM/ISO offered&#8212;in the order presented&#8212;an increasing positive effect.</p><p>The positioning of the SH variable suggested a limited effect coming from the applied treatments.</p></sec></sec><sec sec-type="conclusions" id="sec4-plants-14-02639"><title>4. Conclusions</title><p>The findings of this study suggest that hydroalcoholic extracts from the aerial parts of <italic toggle="yes">Melilotus officinalis</italic> and <italic toggle="yes">M. albus</italic> possess notable cardioprotective potential. Pretreatment with these extracts mitigated isoprenaline-induced myocardial injury in rats, likely through antioxidant mechanisms, as evidenced by improvements in oxidative stress and cardiac injury markers. The presence of bioactive polyphenolic compounds, such as syringic acid, vanillic acid, protocatechuic acid, and catechin further, supports their therapeutic relevance. Notably, <italic toggle="yes">M. officinalis</italic> exhibited unique constituents like gallic acid and chlorogenic acid, which may contribute to its distinct biological effects. Both <italic toggle="yes">Melilotus</italic> species exhibited high total polyphenol content, with substantial levels of flavonoids and coumarins. Overall, these findings suggest that <italic toggle="yes">Melilotus</italic> sp. extracts hold promise as natural agents for the prevention or management of cardiovascular diseases linked to oxidative stress.</p><p>Continued investigation is warranted to isolate and characterize the bioactive constituents and clarify their underlying mechanisms of action. The present findings highlight the therapeutic relevance of both <italic toggle="yes">Melilotus</italic> sp. extracts and introduce novel evidence regarding their cardioprotective effects which had not previously been reported.</p><p>The potential applications of these findings extend to the formulation of functional foods, nutraceutical products, and standardized plant-based preparations designed to support cardiovascular health and potentially mitigate the risk of related disorders. Such applications could be integrated into preventive healthcare strategies, particularly for populations with elevated cardiovascular risk. While the observed bioactivities suggest that dietary supplementation with <italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> may be a viable approach, the current evidence remains preliminary. Before it can be responsibly recommended, further validation through well-designed, large-scale clinical trials is necessary to confirm the efficacy, optimal dosage, and safety profile of the extracts, as well as their standardization in bioactive compounds. In addition, considerations regarding bioavailability, potential interactions with conventional medications, and long-term effects are essential for the responsible translation of these results into public health recommendations.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, A.T., I.O. and A.E.P.; methodology, A.-M.V., L.V., T.C., A.E.P. and A.T.; software and formal analysis&#8212;L.V., T.C. and A.-M.V.; writing&#8212;original draft preparation, A.T., A.-M.V. and I.O.; writing&#8212;review and editing, A.T., A.-M.V., L.V., T.C., A.E.P. and I.O.; supervision, I.O. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This study was conducted in accordance with the guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of Iuliu Ha&#539;ieganu University of Medicine and Pharmacy, Cluj-Napoca (No. 382/25, October 2017), as well as by the National Sanitary Veterinary and Food Safety Authority (No. 94/22, November 2017).</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The raw data supporting the conclusions of this study are available upon request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">ECG</td><td align="left" valign="middle" rowspan="1" colspan="1">Electrocardiogram</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HPLC-MS</td><td align="left" valign="middle" rowspan="1" colspan="1">High-Performance Liquid Chromatography&#8211;Mass Spectrometry</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DPPH</td><td align="left" valign="middle" rowspan="1" colspan="1">2,2-Diphenyl-1-picrylhydrazyl</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FRAP</td><td align="left" valign="middle" rowspan="1" colspan="1">Ferric Reducing Antioxidant Power</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IC<sub>50</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">Half Maximal Inhibitory Concentration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TOS</td><td align="left" valign="middle" rowspan="1" colspan="1">Total Oxidant Status</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">OSI</td><td align="left" valign="middle" rowspan="1" colspan="1">Oxidative Stress Index</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TAC</td><td align="left" valign="middle" rowspan="1" colspan="1">Total Antioxidant Capacity</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MDA</td><td align="left" valign="middle" rowspan="1" colspan="1">Malondialdehyde</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NO</td><td align="left" valign="middle" rowspan="1" colspan="1">Nitric Oxide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SH</td><td align="left" valign="middle" rowspan="1" colspan="1">Total Thiols</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GOT</td><td align="left" valign="middle" rowspan="1" colspan="1">Glutamate Oxaloacetate Transaminase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GPT</td><td align="left" valign="middle" rowspan="1" colspan="1">Glutamate Pyruvate Transaminase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CK-MB</td><td align="left" valign="middle" rowspan="1" colspan="1">Creatine Kinase&#8211;MB Isoenzyme</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CVD</td><td align="left" valign="middle" rowspan="1" colspan="1">Cardiovascular Disease</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IHD</td><td align="left" valign="middle" rowspan="1" colspan="1">Ischemic Heart Disease</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LDL</td><td align="left" valign="middle" rowspan="1" colspan="1">Low-Density Lipoprotein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CRP</td><td align="left" valign="middle" rowspan="1" colspan="1">C-Reactive Protein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ROS</td><td align="left" valign="middle" rowspan="1" colspan="1">Reactive Oxygen Species</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LDH</td><td align="left" valign="middle" rowspan="1" colspan="1">Lactate Dehydrogenase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ATP</td><td align="left" valign="middle" rowspan="1" colspan="1">Adenosine Triphosphate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NAD</td><td align="left" valign="middle" rowspan="1" colspan="1">Nicotinamide Adenine Dinucleotide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SOD</td><td align="left" valign="middle" rowspan="1" colspan="1">Superoxide Dismutase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MO</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Melilotus officinalis</italic>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAS</td><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Melilotus albus</italic>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TPC</td><td align="left" valign="middle" rowspan="1" colspan="1">Total Phenolic Content</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GAE</td><td align="left" valign="middle" rowspan="1" colspan="1">Gallic Acid Equivalents</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TFC</td><td align="left" valign="middle" rowspan="1" colspan="1">Total Flavonoids Content</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RE</td><td align="left" valign="middle" rowspan="1" colspan="1">Rutoside Equivalents</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">QE</td><td align="left" valign="middle" rowspan="1" colspan="1">Quercetin Equivalents</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CUM</td><td align="left" valign="middle" rowspan="1" colspan="1">Coumarin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TCC</td><td align="left" valign="middle" rowspan="1" colspan="1">Total Coumarin Content</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CE</td><td align="left" valign="middle" rowspan="1" colspan="1">Coumarin Equivalents</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TPTZ</td><td align="left" valign="middle" rowspan="1" colspan="1">2,4,6-Tripyridyl-s-triazine</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Trolox</td><td align="left" valign="middle" rowspan="1" colspan="1">6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">APCI</td><td align="left" valign="middle" rowspan="1" colspan="1">Atmospheric Pressure Chemical Ionization </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BW</td><td align="left" valign="middle" rowspan="1" colspan="1">Body Weight</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ISO</td><td align="left" valign="middle" rowspan="1" colspan="1">Isoprenaline</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAPK</td><td align="left" valign="middle" rowspan="1" colspan="1">Mitogen-Activated Protein Kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NF-KB</td><td align="left" valign="middle" rowspan="1" colspan="1">Nuclear Factor Kappa B</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TE</td><td align="left" valign="middle" rowspan="1" colspan="1">Trolox Equivalents</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">INFL</td><td align="left" valign="middle" rowspan="1" colspan="1">Inflammation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CAT</td><td align="left" valign="middle" rowspan="1" colspan="1">Catalase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GSH</td><td align="left" valign="middle" rowspan="1" colspan="1">Glutathione</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GPx</td><td align="left" valign="middle" rowspan="1" colspan="1">Glutathione Peroxidase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">OPLS-DA</td><td align="left" valign="middle" rowspan="1" colspan="1">Orthogonal Projections to Latent Structures based Discriminant Analysis</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PCA</td><td align="left" valign="middle" rowspan="1" colspan="1">Principal Component Analysis</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TNF-alfa</td><td align="left" valign="middle" rowspan="1" colspan="1">Tumor Necrosis Factor-alpha</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL-6</td><td align="left" valign="middle" rowspan="1" colspan="1">Interleukin-6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MI</td><td align="left" valign="middle" rowspan="1" colspan="1">Myocardial Infarction</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LOQ</td><td align="left" valign="middle" rowspan="1" colspan="1">Limit Of Quantification</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-plants-14-02639"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madhumitha</surname><given-names>S.</given-names></name><name name-style="western"><surname>Indhuleka</surname><given-names>A.</given-names></name></person-group><article-title>Cardioprotective Effect of Morus <italic toggle="yes">Alba</italic> L. Leaves in Isoprenaline Induced Rats</article-title><source>Int. J. Pharm. Sci. Res.</source><year>2012</year><volume>3</volume><fpage>1475</fpage><lpage>1480</lpage></element-citation></ref><ref id="B2-plants-14-02639"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ai</surname><given-names>F.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name></person-group><article-title>Cardioprotective Effect of Aloe vera Biomacromolecules Conjugated with Selenium Trace Element on Myocardial Ischemia-Reperfusion Injury in Rats</article-title><source>Biol. Trace Elem. Res.</source><year>2016</year><volume>177</volume><fpage>345</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1007/s12011-016-0896-8</pub-id><pub-id pub-id-type="pmid">27873288</pub-id></element-citation></ref><ref id="B3-plants-14-02639"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Epure</surname><given-names>A.</given-names></name><name name-style="western"><surname>P&#226;rvu</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Vlase</surname><given-names>L.</given-names></name><name name-style="western"><surname>Benedec</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hanganu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Oniga</surname><given-names>O.</given-names></name><name name-style="western"><surname>Vlase</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Ielciu</surname><given-names>I.</given-names></name><name name-style="western"><surname>Toiu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Oniga</surname><given-names>I.</given-names></name></person-group><article-title>New Approaches on the Anti-Inflammatory and Cardioprotective Properties of Taraxacum officinale Tincture</article-title><source>Pharmaceuticals</source><year>2023</year><volume>16</volume><elocation-id>358</elocation-id><pub-id pub-id-type="doi">10.3390/ph16030358</pub-id><pub-id pub-id-type="pmid">36986458</pub-id><pub-id pub-id-type="pmcid">PMC10053582</pub-id></element-citation></ref><ref id="B4-plants-14-02639"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Upaganlawar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gandhi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Balaraman</surname><given-names>R.</given-names></name></person-group><article-title>Isoproterenol induced myocardial infarction: Protective role of natural products</article-title><source>J. Pharmacol. Toxicol.</source><year>2011</year><volume>6</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.3923/jpt.2011.1.17</pub-id></element-citation></ref><ref id="B5-plants-14-02639"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akter</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Islam</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Hossen</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Algheshairy</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Almujaydil</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Alharbi</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Alnajeebi</surname><given-names>A.M.</given-names></name></person-group><article-title>Biometabolites of Tamarindus indica play a remarkable cardioprotective role as a functional food in doxorubicin-induced cardiotoxicity models</article-title><source>J. Funct. Foods</source><year>2022</year><volume>1</volume><fpage>96</fpage><pub-id pub-id-type="doi">10.1016/j.jff.2022.105212</pub-id></element-citation></ref><ref id="B6-plants-14-02639"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Otr&#281;ba</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ko&#347;mider</surname><given-names>L.</given-names></name><name name-style="western"><surname>Stojko</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rzepecka-Stojko</surname><given-names>A.</given-names></name></person-group><article-title>Cardioprotective activity of selected polyphenols based on epithelial and aortic cell lines. A review</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>5343</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25225343</pub-id><pub-id pub-id-type="pmid">33207683</pub-id><pub-id pub-id-type="pmcid">PMC7698279</pub-id></element-citation></ref><ref id="B7-plants-14-02639"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>P.W.</given-names></name><name name-style="western"><surname>Tutin</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>Heywood</surname><given-names>V.H.</given-names></name><name name-style="western"><surname>Burges</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Valentine</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Walters</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Webb</surname><given-names>D.A.</given-names></name></person-group><article-title>Flora Europaea. Vol. 2. Rosaceae to Umbelliferae</article-title><source>J. Ecol.</source><year>1969</year><volume>57</volume><fpage>482</fpage><pub-id pub-id-type="doi">10.2307/2258510</pub-id></element-citation></ref><ref id="B8-plants-14-02639"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chorepsima</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tentolouris</surname><given-names>K.</given-names></name><name name-style="western"><surname>Dimitroulis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tentolouris</surname><given-names>N.</given-names></name></person-group><article-title>Melilotus: Contribution to wound healing in the diabetic foot</article-title><source>J. Herb. Med.</source><year>2013</year><volume>3</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.hermed.2013.04.005</pub-id></element-citation></ref><ref id="B9-plants-14-02639"><label>9.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Cioc&#226;rlan</surname><given-names>V.</given-names></name></person-group><source>Flora ilustrat&#259; a Rom&#226;niei Pteridophyta et Spermatophyta</source><publisher-name>Publishing House Ceres</publisher-name><publisher-loc>Bucure&#351;ti, Romania</publisher-loc><year>2009</year><size units="pages">1141p</size></element-citation></ref><ref id="B10-plants-14-02639"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>C.N.</given-names></name></person-group><article-title>Study on the extraction process of total flavonoids from Melilotus officinalis medicinal plant</article-title><source>J. Anhui Agric. Sci.</source><year>2012</year><volume>3</volume><fpage>23</fpage><lpage>25</lpage></element-citation></ref><ref id="B11-plants-14-02639"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anwer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Azhar</surname><given-names>I.</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mohtasheem</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Bano</surname><given-names>H.</given-names></name></person-group><article-title>Chemical constituents from Melilotus officinalis</article-title><source>J. Basic Appl. Sci.</source><year>2008</year><volume>4</volume><fpage>89</fpage><lpage>94</lpage></element-citation></ref><ref id="B12-plants-14-02639"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stefanovi&#263;</surname><given-names>O.D.</given-names></name><name name-style="western"><surname>Te&#353;i&#263;</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>&#268;omi&#263;</surname><given-names>L.R.</given-names></name></person-group><article-title>Melilotus albus and Dorycnium herbaceum extracts as source of phenolic compounds and their antimicrobial, antibiofilm, and antioxidant potentials</article-title><source>J. Food Drug Anal.</source><year>2015</year><volume>23</volume><fpage>417</fpage><pub-id pub-id-type="doi">10.1016/j.jfda.2015.01.003</pub-id><pub-id pub-id-type="pmid">28911698</pub-id><pub-id pub-id-type="pmcid">PMC9351790</pub-id></element-citation></ref><ref id="B13-plants-14-02639"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sisay</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Mammo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yaya</surname><given-names>E.E.</given-names></name></person-group><article-title>Phytochemical studies of Melilotus officinalis</article-title><source>Bull. Chem. Soc. Ethiop.</source><year>2021</year><volume>35</volume><fpage>141</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.4314/bcse.v35i1.12</pub-id></element-citation></ref><ref id="B14-plants-14-02639"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nogues</surname><given-names>I.</given-names></name><name name-style="western"><surname>Passatore</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bustamante</surname><given-names>M.&#193;.</given-names></name><name name-style="western"><surname>Pallozzi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Luz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Traquete</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>A.E.N.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Cordeiro</surname><given-names>C.</given-names></name></person-group><article-title>Cultivation of Melilotus officinalis as a source of bioactive compounds in association with soil recovery practices</article-title><source>Front. Plant Sci.</source><year>2023</year><volume>14</volume><elocation-id>1218594</elocation-id><pub-id pub-id-type="doi">10.3389/fpls.2023.1218594</pub-id><pub-id pub-id-type="pmid">37771488</pub-id><pub-id pub-id-type="pmcid">PMC10523325</pub-id></element-citation></ref><ref id="B15-plants-14-02639"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trouillas</surname><given-names>P.</given-names></name><name name-style="western"><surname>Calliste</surname><given-names>C.-A.</given-names></name><name name-style="western"><surname>Allais</surname><given-names>D.-P.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>A.</given-names></name><name name-style="western"><surname>Marfak</surname><given-names>A.</given-names></name><name name-style="western"><surname>Delage</surname><given-names>C.</given-names></name><name name-style="western"><surname>Duroux</surname><given-names>J.-L.</given-names></name></person-group><article-title>Antioxidant, anti-inflammatory and antiproliferative properties of sixteen water plant extracts used in the Limousin countryside as herbal teas</article-title><source>Food Chem.</source><year>2003</year><volume>80</volume><fpage>399</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1016/S0308-8146(02)00282-0</pub-id></element-citation></ref><ref id="B16-plants-14-02639"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miliauskas</surname><given-names>G.</given-names></name><name name-style="western"><surname>Venskutonis</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Van Beek</surname><given-names>T.A.</given-names></name></person-group><article-title>Screening of radical scavenging activity of some medicinal and aromatic plant extracts</article-title><source>Food Chem.</source><year>2004</year><volume>85</volume><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2003.05.007</pub-id></element-citation></ref><ref id="B17-plants-14-02639"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pastorino</surname><given-names>G.</given-names></name><name name-style="western"><surname>Marchetti</surname><given-names>C.</given-names></name><name name-style="western"><surname>Borghesi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Cornara</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ribulla</surname><given-names>S.</given-names></name><name name-style="western"><surname>Burlando</surname><given-names>B.</given-names></name></person-group><article-title>Biological activities of the legume crops Melilotus officinalis and Lespedeza capitata for skin care and pharmaceutical applications</article-title><source>Ind. Crops Prod.</source><year>2017</year><volume>96</volume><fpage>158</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2016.11.047</pub-id></element-citation></ref><ref id="B18-plants-14-02639"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>European Medicines Agency</collab></person-group><source>Assessment Report on Melilotus officinalis (L.) Pall., Herba [Internet]</source><publisher-name>EMA</publisher-name><publisher-loc>London, UK</publisher-loc><year>2017</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.fitoterapia.net/archivos/202505/addendum-assessment-report-melilotus-officinalis-l-lam-herba_en.pdf?1" ext-link-type="uri">https://www.fitoterapia.net/archivos/202505/addendum-assessment-report-melilotus-officinalis-l-lam-herba_en.pdf?1</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-05-01">(accessed on 1 May 2025)</date-in-citation></element-citation></ref><ref id="B19-plants-14-02639"><label>19.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>European Directorate for the Quality of Medicines &amp; HealthCare (EDQM)</collab></person-group><article-title>Meliloti herba (Melilotus officinalis herba)</article-title><source>European Pharmacopoeia</source><edition>9th ed.</edition><publisher-name>Council of Europe</publisher-name><publisher-loc>Strasbourg, France</publisher-loc><year>2017</year></element-citation></ref><ref id="B20-plants-14-02639"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoker</surname><given-names>J.R.</given-names></name></person-group><article-title>The biosynthesis of coumarin in Melilotus alba</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1963</year><volume>14</volume><fpage>17</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(63)90203-1</pub-id><pub-id pub-id-type="pmid">5836500</pub-id></element-citation></ref><ref id="B21-plants-14-02639"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nair</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Whittall</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Craig</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Revell</surname><given-names>D.K.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Powell</surname><given-names>T.</given-names></name><name name-style="western"><surname>Auricht</surname><given-names>G.C.</given-names></name></person-group><article-title>Variation in coumarin content of Melilotus species grown in South Australia</article-title><source>N. Z. J. Agric. Res.</source><year>2010</year><volume>53</volume><fpage>201</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1080/00288233.2010.495743</pub-id></element-citation></ref><ref id="B22-plants-14-02639"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radmanesh</surname><given-names>E.</given-names></name><name name-style="western"><surname>Dianat</surname><given-names>M.</given-names></name><name name-style="western"><surname>Badavi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Goudarzi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mard</surname><given-names>S.A.</given-names></name></person-group><article-title>The cardioprotective effect of vanillic acid on hemodynamic parameters, malondialdehyde, and infarct size in ischemia-reperfusion isolated rat heart exposed to PM10</article-title><source>Iran J. Basic Med. Sci.</source><year>2017</year><volume>20</volume><fpage>760</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.22038/ijbms.2017.9007</pub-id><pub-id pub-id-type="pmid">28852440</pub-id><pub-id pub-id-type="pmcid">PMC5569588</pub-id></element-citation></ref><ref id="B23-plants-14-02639"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Safaeian</surname><given-names>L.</given-names></name><name name-style="western"><surname>Baniahmad</surname><given-names>B.</given-names></name><name name-style="western"><surname>Vaseghi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Rabbani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mohammadi</surname><given-names>B.</given-names></name></person-group><article-title>Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat</article-title><source>Res. Pharm. Sci.</source><year>2020</year><volume>15</volume><fpage>87</fpage><pub-id pub-id-type="doi">10.4103/1735-5362.278718</pub-id><pub-id pub-id-type="pmid">32180820</pub-id><pub-id pub-id-type="pmcid">PMC7053285</pub-id></element-citation></ref><ref id="B24-plants-14-02639"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ya</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>F.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ling</surname><given-names>W.</given-names></name><name name-style="western"><surname>Adili</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Protocatechuic Acid Protects Platelets from Apoptosis via Inhibiting Oxidative Stress-Mediated PI3K/Akt/GSK3&#946; Signaling</article-title><source>Thromb. Haemost.</source><year>2021</year><volume>121</volume><fpage>931</fpage><lpage>943</lpage><pub-id pub-id-type="doi">10.1055/s-0040-1722621</pub-id><pub-id pub-id-type="pmid">33545736</pub-id></element-citation></ref><ref id="B25-plants-14-02639"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>B.</given-names></name><name name-style="western"><surname>Al Sberi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Elhefny</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Lokman</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Kassab</surname><given-names>R.B.</given-names></name></person-group><article-title>Protocatechuic acid reverses myocardial infarction mediated by &#946;-adrenergic agonist via regulation of Nrf2/HO-1 pathway, inflammatory, apoptotic, and fibrotic events</article-title><source>J. Biochem. Mol. Toxicol.</source><year>2023</year><volume>37</volume><elocation-id>e23270</elocation-id><pub-id pub-id-type="doi">10.1002/jbt.23270</pub-id><pub-id pub-id-type="pmid">36593721</pub-id></element-citation></ref><ref id="B26-plants-14-02639"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toiu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vlase</surname><given-names>L.</given-names></name><name name-style="western"><surname>Vodnar</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Gheldiu</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Oniga</surname><given-names>I.</given-names></name></person-group><article-title><italic toggle="yes">Solidago graminifolia</italic> L. Salisb. (<italic toggle="yes">Asteraceae</italic>) as a Valuable Source of Bioactive Polyphenols: HPLC Profile, In Vitro Antioxidant and Antimicrobial Potential</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2666</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24142666</pub-id><pub-id pub-id-type="pmid">31340530</pub-id><pub-id pub-id-type="pmcid">PMC6680997</pub-id></element-citation></ref><ref id="B27-plants-14-02639"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vlase</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Toiu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tomu&#539;&#259;</surname><given-names>I.</given-names></name><name name-style="western"><surname>Vlase</surname><given-names>L.</given-names></name><name name-style="western"><surname>Muntean</surname><given-names>D.</given-names></name><name name-style="western"><surname>Casian</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fize&#537;an</surname><given-names>I.</given-names></name><name name-style="western"><surname>Nad&#259;&#537;</surname><given-names>G.C.</given-names></name><name name-style="western"><surname>Novac</surname><given-names>C.&#536;.</given-names></name><name name-style="western"><surname>T&#259;ma&#537;</surname><given-names>M.</given-names></name><etal/></person-group><article-title><italic toggle="yes">Epilobium</italic> Species: From Optimization of the Extraction Process to Evaluation of Biological Properties</article-title><source>Antioxidants</source><year>2023</year><volume>12</volume><elocation-id>91</elocation-id><pub-id pub-id-type="doi">10.3390/antiox12010091</pub-id><pub-id pub-id-type="pmcid">PMC9854965</pub-id><pub-id pub-id-type="pmid">36670952</pub-id></element-citation></ref><ref id="B28-plants-14-02639"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsieh</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>J.C.</given-names></name></person-group><article-title>Antioxidant and hepatoprotective effects of Ajuga nipponensis extract by ultrasonic-assisted extraction</article-title><source>Asian Pac. J. Trop. Med.</source><year>2016</year><volume>9</volume><fpage>420</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.apjtm.2016.03.029</pub-id><pub-id pub-id-type="pmid">27261848</pub-id></element-citation></ref><ref id="B29-plants-14-02639"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toiu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mocan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vlase</surname><given-names>L.</given-names></name><name name-style="western"><surname>P&#226;rvu</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Vodnar</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Gheldiu</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Moldovan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Oniga</surname><given-names>I.</given-names></name></person-group><article-title>Phytochemical composition, antioxidant, antimicrobial and in vivo anti-inflammatory activity of traditionally used Romanian Ajuga laxmannii (Murray) Benth. (&#8216;nobleman&#8217;s beard&#8217; - barba &#238;mp&#259;ratului)</article-title><source>Front. Pharmacol.</source><year>2018</year><volume>9</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2018.00007</pub-id><pub-id pub-id-type="pmid">29551972</pub-id><pub-id pub-id-type="pmcid">PMC5840282</pub-id></element-citation></ref><ref id="B30-plants-14-02639"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toiu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mocan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vlase</surname><given-names>L.</given-names></name><name name-style="western"><surname>P&#226;rvu</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Vodnar</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Gheldiu</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Moldovan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Oniga</surname><given-names>I.</given-names></name></person-group><article-title>Comparative Phytochemical Profile, Antioxidant, Antimicrobial and <italic toggle="yes">In Vivo</italic> Anti-Inflammatory Activity of Different Extracts of Traditionally Used Romanian <italic toggle="yes">Ajuga genevensis</italic> L. and <italic toggle="yes">A. reptans</italic> L. (Lamiaceae)</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1597</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24081597</pub-id><pub-id pub-id-type="pmid">31018502</pub-id><pub-id pub-id-type="pmcid">PMC6515068</pub-id></element-citation></ref><ref id="B31-plants-14-02639"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Os&#243;rio Ade</surname><given-names>C.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>J.L.S.</given-names></name></person-group><article-title>Determina&#231;&#227;o de cumarina em extrato fluido e tintura de guaco por espectrofotometria derivada de primeira ordem</article-title><source>Rev. Bras. Ci&#234;nc. Farm.</source><year>2004</year><volume>40</volume><fpage>481</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1590/S1516-93322004000400005</pub-id></element-citation></ref><ref id="B32-plants-14-02639"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balea</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>P&#226;rvu</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Pop</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>F.Z.</given-names></name><name name-style="western"><surname>P&#226;rvu</surname><given-names>M.</given-names></name></person-group><article-title>Polyphenolic compounds, antioxidant, and cardioprotective effects of pomace extracts from Feteasc&#259; neagr&#259; cultivar</article-title><source>Oxid. Med. Cell Longev.</source><year>2018</year><volume>2018</volume><fpage>8194721</fpage><pub-id pub-id-type="doi">10.1155/2018/8194721</pub-id><pub-id pub-id-type="pmid">29765504</pub-id><pub-id pub-id-type="pmcid">PMC5885407</pub-id></element-citation></ref><ref id="B33-plants-14-02639"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarac</surname><given-names>F.</given-names></name><name name-style="western"><surname>Yeniocak</surname><given-names>S.</given-names></name><name name-style="western"><surname>Erbin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yucetas</surname><given-names>E.</given-names></name><name name-style="western"><surname>Altundal</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ucpinar</surname><given-names>B.</given-names></name><name name-style="western"><surname>Saygili</surname><given-names>A.</given-names></name><name name-style="western"><surname>Koldas</surname><given-names>M.</given-names></name></person-group><article-title>Ischemia Modified Albumin and D-dimer in the Diagnosis of Testicular Torsion: An Experimental Model</article-title><source>Urol. J.</source><year>2019</year><volume>16</volume><fpage>567</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">31119719</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.22037/uj.v0i0.4974</pub-id></element-citation></ref><ref id="B34-plants-14-02639"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ziaee</surname><given-names>M.</given-names></name><name name-style="western"><surname>Khorrami</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ebrahimi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nourafcan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Amiraslanzadeh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rameshrad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garjani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garjani</surname><given-names>A.</given-names></name></person-group><article-title>Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat</article-title><source>Iran J. Pharm. Res.</source><year>2015</year><volume>14</volume><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">25561934</pub-id><pub-id pub-id-type="pmcid">PMC4277641</pub-id></element-citation></ref><ref id="B35-plants-14-02639"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Konopelski</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ufnal</surname><given-names>M.</given-names></name></person-group><article-title>Electrocardiography in rats: A comparison to human</article-title><source>Physiol. Res.</source><year>2016</year><volume>65</volume><fpage>717</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.33549/physiolres.933270</pub-id><pub-id pub-id-type="pmid">27429108</pub-id></element-citation></ref><ref id="B36-plants-14-02639"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erel</surname><given-names>O.</given-names></name></person-group><article-title>A new automated colorimetric method for measuring total oxidant status</article-title><source>Clin. Biochem.</source><year>2005</year><volume>38</volume><fpage>1103</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2005.08.008</pub-id><pub-id pub-id-type="pmid">16214125</pub-id></element-citation></ref><ref id="B37-plants-14-02639"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erel</surname><given-names>O.</given-names></name></person-group><article-title>A novel automated method to measure total antioxidant response against potent free radical reactions</article-title><source>Clin. Biochem.</source><year>2004</year><volume>37</volume><fpage>112</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2003.10.014</pub-id><pub-id pub-id-type="pmid">14725941</pub-id></element-citation></ref><ref id="B38-plants-14-02639"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harma</surname><given-names>M.</given-names></name><name name-style="western"><surname>Erel</surname><given-names>O.</given-names></name></person-group><article-title>Increased oxidative stress in patients with hydatidiform mole</article-title><source>Swiss Med. Wkly.</source><year>2003</year><volume>133</volume><fpage>563</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.4414/smw.2003.10397</pub-id><pub-id pub-id-type="pmid">14691728</pub-id></element-citation></ref><ref id="B39-plants-14-02639"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muti</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>P&#226;rvu</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Cr&#259;ciun</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Miron</surname><given-names>N.</given-names></name><name name-style="western"><surname>Acalovschi</surname><given-names>M.</given-names></name></person-group><article-title>Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension</article-title><source>Clujul Med.</source><year>2015</year><volume>88</volume><fpage>140</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.15386/cjmed-458</pub-id><pub-id pub-id-type="pmid">26528062</pub-id><pub-id pub-id-type="pmcid">PMC4576785</pub-id></element-citation></ref><ref id="B40-plants-14-02639"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Draper</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Squires</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Mahmoodi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hadley</surname><given-names>M.</given-names></name></person-group><article-title>A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials</article-title><source>Free Radic. Biol. Med.</source><year>1993</year><volume>15</volume><fpage>353</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/0891-5849(93)90035-S</pub-id><pub-id pub-id-type="pmid">8225017</pub-id></element-citation></ref><ref id="B41-plants-14-02639"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>M.L.</given-names></name></person-group><article-title>Measurement of protein thiol groups and glutathione in plasma</article-title><source>Methods Enzymol.</source><year>1994</year><volume>233</volume><fpage>380</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">8015473</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0076-6879(94)33044-1</pub-id></element-citation></ref><ref id="B42-plants-14-02639"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghasemi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hedayati</surname><given-names>M.</given-names></name><name name-style="western"><surname>Biabani</surname><given-names>H.</given-names></name></person-group><article-title>Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess Assay</article-title><source>JMSR</source><year>2007</year><volume>2</volume><fpage>29</fpage><lpage>32</lpage></element-citation></ref><ref id="B43-plants-14-02639"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miranda</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Espey</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Wink</surname><given-names>D.A.</given-names></name></person-group><article-title>A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite</article-title><source>Nitric Oxide</source><year>2001</year><volume>5</volume><fpage>62</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1006/niox.2000.0319</pub-id><pub-id pub-id-type="pmid">11178938</pub-id></element-citation></ref><ref id="B44-plants-14-02639"><label>44.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Eriksson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Byrne</surname><given-names>T.</given-names></name><name name-style="western"><surname>Johansson</surname><given-names>E.</given-names></name><name name-style="western"><surname>Trygg</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vikstr&#246;m</surname><given-names>C.</given-names></name></person-group><source>Multi- and Megavariate Data Analysis: Basic Principles and Applications</source><edition>3rd ed.</edition><publisher-name>MKS Umetrics AB</publisher-name><publisher-loc>Malmo, Sweden</publisher-loc><year>2013</year><volume>Volume 1</volume></element-citation></ref><ref id="B45-plants-14-02639"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiklund</surname><given-names>S.</given-names></name><name name-style="western"><surname>Johansson</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sj&#246;str&#246;m</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mellerowicz</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Edlund</surname><given-names>U.</given-names></name><name name-style="western"><surname>Shockcor</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Gottfries</surname><given-names>J.</given-names></name><name name-style="western"><surname>Moritz</surname><given-names>T.</given-names></name><name name-style="western"><surname>Trygg</surname><given-names>J.</given-names></name></person-group><article-title>Visualization of GC/TOF-MS-Based Metabolomics Data for Identification of Biochemically Interesting Compounds Using OPLS Class Models</article-title><source>Anal. Chem.</source><year>2008</year><volume>80</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1021/ac0713510</pub-id><pub-id pub-id-type="pmid">18027910</pub-id></element-citation></ref><ref id="B46-plants-14-02639"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ayadi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bennani</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Aarab</surname><given-names>A.</given-names></name><name name-style="western"><surname>Brigui</surname><given-names>J.</given-names></name><name name-style="western"><surname>Benicha</surname><given-names>M.</given-names></name></person-group><article-title>Content of polyphenolic compounds in Melilotus officinalis ecotypes from Morocco</article-title><source>Options M&#233;diterran&#233;ennes</source><year>2021</year><volume>125</volume><fpage>559</fpage><lpage>563</lpage></element-citation></ref><ref id="B47-plants-14-02639"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szyma&#324;ski</surname><given-names>M.</given-names></name><name name-style="western"><surname>Szajkowska</surname><given-names>D.</given-names></name><name name-style="western"><surname>Szyma&#324;ski</surname><given-names>A.</given-names></name></person-group><article-title>Analiza fitochemiczna gatunk&#243;w Melilotus officinalis i Melilotus alba</article-title><source>Post&#281;py Fitoter.</source><year>2020</year><volume>21</volume><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.25121/PF.2020.21.4.207</pub-id></element-citation></ref><ref id="B48-plants-14-02639"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merghem</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dahamna</surname><given-names>S.</given-names></name></person-group><article-title>Evaluation of Antioxidant Activity and Polyphenols Contents of Melilotus indicus Extracts</article-title><source>Indian J. Nat. Sci.</source><year>2021</year><volume>12</volume><fpage>125</fpage><lpage>130</lpage></element-citation></ref><ref id="B49-plants-14-02639"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borhani</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mazandarani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abbaspour</surname><given-names>H.</given-names></name></person-group><article-title>Antioxidant, Antibacterial Activity, Ethnopharmacology, Phytochemical in Different Extracts of <italic toggle="yes">Melilotus officinalis</italic> L. as an Anti-infection and Anti-diabetic in Traditional Uses of Two Northern Provinces From Iran</article-title><source>Crescent J. Med. Biol. Sci.</source><year>2024</year><volume>11</volume><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.34172/cjmb.2024.3012</pub-id></element-citation></ref><ref id="B50-plants-14-02639"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nechita</surname><given-names>M.-A.</given-names></name><name name-style="western"><surname>Toiu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Benedec</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hanganu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ielciu</surname><given-names>I.</given-names></name><name name-style="western"><surname>Oniga</surname><given-names>O.</given-names></name><name name-style="western"><surname>Nechita</surname><given-names>V.-I.</given-names></name><name name-style="western"><surname>Oniga</surname><given-names>I.</given-names></name></person-group><article-title><italic toggle="yes">Agastache</italic> species: A comprehensive review on phytochemical composition and therapeutic properties</article-title><source>Plants</source><year>2023</year><volume>12</volume><elocation-id>2937</elocation-id><pub-id pub-id-type="doi">10.3390/plants12162937</pub-id><pub-id pub-id-type="pmid">37631149</pub-id><pub-id pub-id-type="pmcid">PMC10459224</pub-id></element-citation></ref><ref id="B51-plants-14-02639"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toiu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vlase</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gheldiu</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Vodnar</surname><given-names>D.</given-names></name><name name-style="western"><surname>Oniga</surname><given-names>I.</given-names></name></person-group><article-title>Evaluation of the Antioxidant and Antibacterial Potential of Bioactive Compounds from Ajuga Reptans Extracts</article-title><source>Farmacia</source><year>2017</year><volume>65</volume><fpage>351</fpage><lpage>355</lpage></element-citation></ref><ref id="B52-plants-14-02639"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaur</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gulati</surname><given-names>M.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Kuppusamy</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kapoor</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>V.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Arshad</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Porwal</surname><given-names>O.</given-names></name><name name-style="western"><surname>Jha</surname><given-names>N.K.</given-names></name><etal/></person-group><article-title>Discovering multifaceted role of vanillic acid beyond flavours: Nutraceutical and therapeutic potential</article-title><source>Trends Food Sci. Technol.</source><year>2022</year><volume>122</volume><fpage>187</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1016/j.tifs.2022.02.023</pub-id></element-citation></ref><ref id="B53-plants-14-02639"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magiera</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ko&#322;odziejczyk-Czepas</surname><given-names>J.</given-names></name><name name-style="western"><surname>Olszewska</surname><given-names>M.A.</given-names></name></person-group><article-title>Antioxidant and Anti-Inflammatory Effects of Vanillic Acid in Human Plasma, Human Neutrophils, and Non-Cellular Models In Vitro</article-title><source>Molecules</source><year>2025</year><volume>30</volume><elocation-id>467</elocation-id><pub-id pub-id-type="doi">10.3390/molecules30030467</pub-id><pub-id pub-id-type="pmid">39942571</pub-id><pub-id pub-id-type="pmcid">PMC11820348</pub-id></element-citation></ref><ref id="B54-plants-14-02639"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>J.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ran</surname><given-names>F.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ci</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Han</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D.</given-names></name></person-group><article-title>New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily</article-title><source>Pharmacol. Res.</source><year>2020</year><volume>161</volume><fpage>105109</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2020.105109</pub-id><pub-id pub-id-type="pmid">32738494</pub-id></element-citation></ref><ref id="B55-plants-14-02639"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masella</surname><given-names>R.</given-names></name><name name-style="western"><surname>Santangelo</surname><given-names>C.</given-names></name><name name-style="western"><surname>D&#8217;Archivio</surname><given-names>M.</given-names></name><name name-style="western"><surname>LiVolti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Giovannini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Galvano</surname><given-names>F.</given-names></name></person-group><article-title>Protocatechuic Acid and Human Disease Prevention: Biological Activities and Molecular Mechanisms</article-title><source>Curr. Med. Chem.</source><year>2012</year><volume>19</volume><fpage>2901</fpage><lpage>2917</lpage><pub-id pub-id-type="doi">10.2174/092986712800672102</pub-id><pub-id pub-id-type="pmid">22519395</pub-id></element-citation></ref><ref id="B56-plants-14-02639"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sowa-Borowiec</surname><given-names>P.</given-names></name><name name-style="western"><surname>Czernicka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jarecki</surname><given-names>W.</given-names></name><name name-style="western"><surname>D&#380;ugan</surname><given-names>M.</given-names></name></person-group><article-title>Sweet Clover (<italic toggle="yes">Melilotus</italic> spp.) as a Source of Biologically Active Compounds</article-title><source>Molecules</source><year>2025</year><volume>30</volume><elocation-id>526</elocation-id><pub-id pub-id-type="doi">10.3390/molecules30030526</pub-id><pub-id pub-id-type="pmid">39942630</pub-id><pub-id pub-id-type="pmcid">PMC11820964</pub-id></element-citation></ref><ref id="B57-plants-14-02639"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Snafi</surname><given-names>A.E.</given-names></name></person-group><article-title>Chemical Constituents and Pharmacological Effects of Melilotus Officinalis&#8212;A Review</article-title><source>IOSR J. Pharm.</source><year>2020</year><volume>10</volume><fpage>26</fpage><lpage>36</lpage></element-citation></ref><ref id="B58-plants-14-02639"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamad</surname><given-names>I.</given-names></name><name name-style="western"><surname>Arda</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pekmez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Karaer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Temizkan</surname><given-names>G.</given-names></name></person-group><article-title>Intracellular scavenging activity of Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid) in the fission yeast, Schizosaccharomyces pombe</article-title><source>J. Nat. Sci. Biol. Med.</source><year>2010</year><volume>1</volume><fpage>16</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.4103/0976-9668.71667</pub-id><pub-id pub-id-type="pmid">22096330</pub-id><pub-id pub-id-type="pmcid">PMC3217288</pub-id></element-citation></ref><ref id="B59-plants-14-02639"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srinivasulu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ramgopal</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ramanjaneyulu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Anuradha</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Suresh Kumar</surname><given-names>C.</given-names></name></person-group><article-title>Syringic acid (SA)&#8212;A Review of Its Occurrence, Biosynthesis, Pharmacological and Industrial Importance</article-title><source>Biomed Pharmacother.</source><year>2018</year><volume>108</volume><fpage>547</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.09.069</pub-id><pub-id pub-id-type="pmid">30243088</pub-id></element-citation></ref><ref id="B60-plants-14-02639"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bartel</surname><given-names>I.</given-names></name><name name-style="western"><surname>Mandryk</surname><given-names>I.</given-names></name><name name-style="western"><surname>Horba&#324;czuk</surname><given-names>J.O.</given-names></name><name name-style="western"><surname>Wierzbicka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Koszarska</surname><given-names>M.</given-names></name></person-group><article-title>Nutraceutical Properties of Syringic Acid in Civilization Diseases&#8212;Review</article-title><source>Nutrients</source><year>2023</year><volume>16</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.3390/nu16010010</pub-id><pub-id pub-id-type="pmid">38201840</pub-id><pub-id pub-id-type="pmcid">PMC10780450</pub-id></element-citation></ref><ref id="B61-plants-14-02639"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahzad</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mateen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Naeem</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Akhtar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rizvi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Moin</surname><given-names>S.</given-names></name></person-group><article-title>Syringic acid protects from isoproterenol induced cardiotoxicity in rats</article-title><source>Eur. J. Pharmacol.</source><year>2019</year><volume>849</volume><fpage>135</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2019.01.056</pub-id><pub-id pub-id-type="pmid">30731086</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="plants-14-02639-f001" orientation="portrait"><label>Figure 1</label><caption><p>The interpretation of SUS plots. Note: shared effects: Diagonal A&#8212;variables influenced in the same direction. Diagonal B&#8212;variables influenced in opposite direction with respect to the (&#8722;) control. Unique effects&#8212;unique decrease (Region 1) and unique increase (Region 2) induced by &#8220;treatment&#8221;; unique increase (Region 3) and unique decrease (Region 4) induced by (+) control.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="plants-14-02639-g001.jpg"/></fig><fig position="float" id="plants-14-02639-f002" orientation="portrait"><label>Figure 2</label><caption><p>Biplot of PCA model.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="plants-14-02639-g002.jpg"/></fig><fig position="float" id="plants-14-02639-f003" orientation="portrait"><label>Figure 3</label><caption><p>SUS plots generated by representing the p(corr) vector of OPLS-DA models developed between the control and other treatments (M4 Control vs. ISO; (<bold>a</bold>) M5&#8212;Control vs. ISO/CUM; (<bold>b</bold>) M6&#8212;Control vs. MO2 /ISO; (<bold>c</bold>) M7&#8212;Control vs. MA2/ISO).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="plants-14-02639-g003.jpg"/></fig><table-wrap position="float" id="plants-14-02639-t001" orientation="portrait"><object-id pub-id-type="pii">plants-14-02639-t001_Table 1</object-id><label>Table 1</label><caption><p><italic toggle="yes">M. officinalis</italic> and <italic toggle="yes">M. albus</italic> samples, voucher specimens, and GPS coordinates of harvesting places.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant<break/>Species</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Voucher Specimen</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Harvesting Place<break/>(GPS Coordinates)</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MO1</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Melilotus officinalis</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MO-5</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cluj County (Lat. 46&#176;83&#8242;64.37&#8243; N,<break/>Long. 23&#176;63&#8242;19.88&#8242;&#8242; E)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MO2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Melilotus officinalis</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MO-8</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brasov County (Lat. 45&#176;39&#8242;48.57&#8243; N,<break/>Long. 25&#176;30&#8242;21.13&#8243; E)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MA1</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Melilotus albus</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MA-4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cluj County (Lat. 46&#176;48&#8242;22.88&#8243; N,<break/>Long. 23&#176;35&#8242;17.77&#8243; E)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MA2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Melilotus albus</italic>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MA-7</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alba County (Lat. 46&#176;18&#8242;22.51&#8243; N,<break/>Long. 23&#176;07&#8242;51.55&#8243; E)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="plants-14-02639-t002" orientation="portrait"><object-id pub-id-type="pii">plants-14-02639-t002_Table 2</object-id><label>Table 2</label><caption><p>The quantitative analysis of bioactive compounds from <italic toggle="yes">Melilotus</italic> sp. extracts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extract</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">TPC <break/>(mg GAE/g de)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">TFC<break/>(mg RE/g de)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">TCC<break/>(mg CE/g de)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">MO1</td><td align="left" valign="middle" rowspan="1" colspan="1">86.516 &#177; 0.98</td><td align="left" valign="middle" rowspan="1" colspan="1">34.752 &#177; 0.57</td><td align="left" valign="middle" rowspan="1" colspan="1">18.473 &#177; 0.63</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MO2</td><td align="left" valign="middle" rowspan="1" colspan="1">138.157 &#177; 3.91</td><td align="left" valign="middle" rowspan="1" colspan="1">78.201 &#177; 1.63</td><td align="left" valign="middle" rowspan="1" colspan="1">47.691 &#177; 0.95</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MA1</td><td align="left" valign="middle" rowspan="1" colspan="1">121.995 &#177; 3.05</td><td align="left" valign="middle" rowspan="1" colspan="1">77.278 &#177; 2.02</td><td align="left" valign="middle" rowspan="1" colspan="1">26.877 &#177; 0.55</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MA2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">127.279 &#177; 3.48</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.105 &#177; 1.66</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.331 &#177; 0.58</td></tr></tbody></table><table-wrap-foot><fn><p>Note: de&#8212;dried extract; TPC&#8212;total phenolic content; GAE&#8212;gallic acid derivatives; TFC&#8212;total flavonoid content; RE&#8212;rutin equivalent; TCC&#8212;total coumarin content; CE&#8212;coumarin equivalent. Each value represents the mean of three determinations &#177; SD.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="plants-14-02639-t003" orientation="portrait"><object-id pub-id-type="pii">plants-14-02639-t003_Table 3</object-id><label>Table 3</label><caption><p>Polyphenolic composition of MO2 and MA2 ethanol extracts by LC-MS (mg/100 g extract).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">[M &#8722; H]<sup>&#8722;</sup><break/><italic toggle="yes">m</italic>/<italic toggle="yes">z</italic></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Polyphenolic<break/>Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">LOQ<break/>&#956;g/mL</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Daughter Ions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">R<sub>T</sub>&#160;<sup>a,b,c</sup> &#177; SD<break/>(min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Polyphenol Content<break/>MO2</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Polyphenol Content<break/>MA2</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">311</td><td align="center" valign="middle" rowspan="1" colspan="1">Caftaric acid <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">148.6, 178.6</td><td align="center" valign="middle" rowspan="1" colspan="1">3.34 <sup>b</sup> &#177; 0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;LOQ</td><td align="center" valign="middle" rowspan="1" colspan="1">nd</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">353</td><td align="center" valign="middle" rowspan="1" colspan="1">Chlorogenic acid <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">178.7, 190.7</td><td align="center" valign="middle" rowspan="1" colspan="1">5.6 <sup>b</sup> &#177; 0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">4.33 &#177; 0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">nd</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">163</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Coumaric acid <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">118.7</td><td align="center" valign="middle" rowspan="1" colspan="1">9.18 <sup>b</sup> &#177; 0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;LOQ</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;LOQ</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">193</td><td align="center" valign="middle" rowspan="1" colspan="1">Ferulic acid <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">133.7, 148.7, 177.6</td><td align="center" valign="middle" rowspan="1" colspan="1">12.8 <sup>b</sup> &#177; 0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">1.28 &#177; 0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0.69 &#177; 0.02</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">169</td><td align="center" valign="middle" rowspan="1" colspan="1">Gallic acid <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">169 *</td><td align="center" valign="middle" rowspan="1" colspan="1">1.5 <sup>c</sup> &#177; 0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">12.06 &#177; 0.37</td><td align="center" valign="middle" rowspan="1" colspan="1">nd</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">153</td><td align="center" valign="middle" rowspan="1" colspan="1">Protocatechuic acid <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">153 *</td><td align="center" valign="middle" rowspan="1" colspan="1">2.8 <sup>c</sup> &#177; 0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">40.64 &#177; 3.51</td><td align="center" valign="middle" rowspan="1" colspan="1">8.01 &#177; 0.85</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">167</td><td align="center" valign="middle" rowspan="1" colspan="1">Vanillic acid <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">167 *</td><td align="center" valign="middle" rowspan="1" colspan="1">6.7 <sup>c</sup> &#177; 0.17</td><td align="center" valign="middle" rowspan="1" colspan="1">57.37 &#177; 2.36</td><td align="center" valign="middle" rowspan="1" colspan="1">23.48 &#177; 1.91</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">197</td><td align="center" valign="middle" rowspan="1" colspan="1">Syringic acid <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">197 *</td><td align="center" valign="middle" rowspan="1" colspan="1">8.4 <sup>c</sup> &#177; 0.11</td><td align="center" valign="middle" rowspan="1" colspan="1">11.55 &#177; 1.74</td><td align="center" valign="middle" rowspan="1" colspan="1">2.6 &#177; 0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">289</td><td align="center" valign="middle" rowspan="1" colspan="1">Catechin <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">289 *</td><td align="center" valign="middle" rowspan="1" colspan="1">6.00 <sup>c</sup> &#177; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">2.02 &#177; 0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">1.84 &#177; 0.06</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">359</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rosmarinic acid <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">160.6, 178.6, 196.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.2 <sup>a</sup> &#177; 0.18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.51 &#177; 0.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;LOQ</td></tr></tbody></table><table-wrap-foot><fn><p>Note: &lt;LOQ&#8212;below limit of quantification; nd&#8212;not determined; <sup>a</sup>&#8212;method a for HPLC analysis; <sup>b</sup>&#8212;method b for HPLC analysis; <sup>c</sup>&#8212;method c for HPLC analysis. Each value represents the mean of three determinations &#177; SD; *&#8212;MS1 (SIM) analysis mode.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="plants-14-02639-t004" orientation="portrait"><object-id pub-id-type="pii">plants-14-02639-t004_Table 4</object-id><label>Table 4</label><caption><p>In vitro antioxidant effect (MO1, MO2, MA1, MA2).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extract</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">DPPH Method<break/>IC<sub>50</sub> (&#956;g TE /mL)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">FRAP Method<break/>&#956;M TE/100 mL</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>MO1</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">118.036 &#177; 2.84</td><td align="left" valign="middle" rowspan="1" colspan="1">193.55 &#177; 3.24</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>MO2</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">92.192 &#177; 2.63</td><td align="left" valign="middle" rowspan="1" colspan="1">279.35 &#177; 4.96</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>MA1</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">73.256 &#177; 2.04</td><td align="left" valign="middle" rowspan="1" colspan="1">489.89 &#177; 8.71</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>MA2</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.193 &#177; 1.45</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">702.92 &#177; 9.65</td></tr></tbody></table><table-wrap-foot><fn><p>Note: TE&#8212;Trolox equivalent; IC<sub>50</sub>&#8212;half-maximal inhibitory concentration. Each value represents the mean of three replicates &#177; SD.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="plants-14-02639-t005" orientation="portrait"><object-id pub-id-type="pii">plants-14-02639-t005_Table 5</object-id><label>Table 5</label><caption><p>Markers of in vivo oxidative stress for MO2 and MA2 extracts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
Group
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
TAC
<break/>
(mM TE/L)
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
TOS
<break/>
(&#956;M H<sub>2</sub>O<sub>2</sub> E/L)
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
OSI
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
NO<sub>x</sub>
<break/>
(&#956;M/L)
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
MDA
<break/>
(&#956;M/L)
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
SH
<break/>
(&#956;M/L)
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CONTROL</td><td align="left" valign="middle" rowspan="1" colspan="1">1.088 &#177; 0.001</td><td align="left" valign="middle" rowspan="1" colspan="1">18.008 ** &#177; 2.182</td><td align="left" valign="middle" rowspan="1" colspan="1">16.538 ** &#177; 1.996</td><td align="left" valign="middle" rowspan="1" colspan="1">27.564 *** &#177; 2.234</td><td align="left" valign="middle" rowspan="1" colspan="1">2.530 *** &#177; 0.334</td><td align="left" valign="middle" rowspan="1" colspan="1">444.400 *** &#177; 53.785</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ISO</td><td align="left" valign="middle" rowspan="1" colspan="1">1.088 &#177; 0.001</td><td align="left" valign="middle" rowspan="1" colspan="1">32.456 &#177; 3.975</td><td align="left" valign="middle" rowspan="1" colspan="1">29.086 &#177; 4.559</td><td align="left" valign="middle" rowspan="1" colspan="1">41.820 &#177; 2.147</td><td align="left" valign="middle" rowspan="1" colspan="1">3.902 &#177; 0.417</td><td align="left" valign="middle" rowspan="1" colspan="1">377.200 &#177; 58.178</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MO2/ISO</td><td align="left" valign="middle" rowspan="1" colspan="1">1.090 <sup>#</sup> &#177; 0.002</td><td align="left" valign="middle" rowspan="1" colspan="1">33.084 &#177; 6.415</td><td align="left" valign="middle" rowspan="1" colspan="1">31.247 &#177; 6.412</td><td align="left" valign="middle" rowspan="1" colspan="1">33.347 <sup>#</sup> &#177; 5.277</td><td align="left" valign="middle" rowspan="1" colspan="1">3.243 <sup>###</sup> &#177; 0.042</td><td align="left" valign="middle" rowspan="1" colspan="1">561.000 <sup>###</sup> &#177; 106.151</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MA2/ISO</td><td align="left" valign="middle" rowspan="1" colspan="1">1.090 <sup>#</sup> &#177; 0.002</td><td align="left" valign="middle" rowspan="1" colspan="1">24.746 <sup>#</sup> &#177; 3.853</td><td align="left" valign="middle" rowspan="1" colspan="1">21.857 <sup>#</sup>&#177; 4.158</td><td align="left" valign="middle" rowspan="1" colspan="1">31.407 <sup>##</sup> &#177; 0.730</td><td align="left" valign="middle" rowspan="1" colspan="1">3.447 <sup>###</sup> &#177; 0.163</td><td align="left" valign="middle" rowspan="1" colspan="1">404.750 <sup>#</sup> &#177; 16.029</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CUM/ISO</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.091 <sup>##</sup> &#177; 0.001</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.310 &#177; 1.210</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.944 &#177; 1.108</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.242 &#177; 4.833</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.528 <sup>##</sup> &#177; 0.430</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">444.800 <sup>###</sup> &#177; 83.125</td></tr></tbody></table><table-wrap-foot><fn><p>Note: * <italic toggle="yes">p</italic> &lt; 0.05; ** <italic toggle="yes">p</italic> &lt; 0.01; *** <italic toggle="yes">p</italic> &lt; 0.001 versus CONTROL; <sup>#</sup>&#160;<italic toggle="yes">p</italic> &lt; 0.05; <sup>##</sup>&#160;<italic toggle="yes">p</italic> &lt; 0.01; <sup>###</sup>&#160;<italic toggle="yes">p</italic> &lt; 0.001 versus ISO. TOS&#8212;total oxidative status; OSI&#8212;oxidative stress index; TAC&#8212;total antioxidant capacity; NO<sub>x</sub>&#8212;total nitrites and nitrates; MDA&#8212;malondialdehyde; SH&#8212;total thiols; TE&#8212;Trolox equivalents; U/L&#8212;units/liter. Each experimental group included five animals. Treatment groups and the doses administered: CONTROL&#8212;0.9% saline solution, 1 mL/rat/day, no myocardial induction of infarction; ISO&#8212;distilled water, 1 mL/rat/day + isoprenaline (150 mg/kg) s.c. on days 8 and 9 for myocardial infarction induction; MO2&#8212;<italic toggle="yes">Melilotus officinalis</italic> extract 1 mL/day by gavage, for 7 days + isoprenaline; MA2&#8212;<italic toggle="yes">Melilotus albus</italic> extract 1 mL/day by gavage, for 7 days + isoprenaline; CUM&#8212;coumarin solution by gavage 25 mg/kg, for 7 days + isoprenaline. Values are expressed as mean &#177; SD (n = 5).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="plants-14-02639-t006" orientation="portrait"><object-id pub-id-type="pii">plants-14-02639-t006_Table 6</object-id><label>Table 6</label><caption><p>Cardiac markers for in vivo cardioprotective evaluation of MO2 and MA2 extracts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Group</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">GOT<break/>(U/L)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">GPT<break/>(U/L)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CK-MB<break/>(U/L)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CONTROL</td><td align="left" valign="middle" rowspan="1" colspan="1">34.400 *** &#177; 4.506</td><td align="left" valign="middle" rowspan="1" colspan="1">37.200 *** &#177; 4.266</td><td align="left" valign="middle" rowspan="1" colspan="1">8.000 *** &#177; 1.732</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ISO</td><td align="left" valign="middle" rowspan="1" colspan="1">84.800 &#177; 32.568</td><td align="left" valign="middle" rowspan="1" colspan="1">87.600 &#177; 28.962</td><td align="left" valign="middle" rowspan="1" colspan="1">17.600 &#177; 3.209</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MO2/ISO</td><td align="left" valign="middle" rowspan="1" colspan="1">76.667 &#177; 1.528</td><td align="left" valign="middle" rowspan="1" colspan="1">78.667 &#177; 11.060</td><td align="left" valign="middle" rowspan="1" colspan="1">7.333 <sup>###</sup> &#177; 3.055</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MA2/ISO</td><td align="left" valign="middle" rowspan="1" colspan="1">55.000 <sup>##</sup> &#177; 29.597</td><td align="left" valign="middle" rowspan="1" colspan="1">60.667 <sup>###</sup> &#177; 29.771</td><td align="left" valign="middle" rowspan="1" colspan="1">8.667 <sup>###</sup> &#177; 0.577</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CUM/ISO</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77.800 &#177; 12.518</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85.800 &#177; 17.584</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.800 <sup>###</sup> &#177; 1.304</td></tr></tbody></table><table-wrap-foot><fn><p>Note: * <italic toggle="yes">p</italic> &lt; 0.05; ** <italic toggle="yes">p</italic> &lt; 0.01; *** <italic toggle="yes">p</italic> &lt; 0.001 versus CONTROL; <sup>#</sup>&#160;<italic toggle="yes">p</italic> &lt; 0.05; <sup>##</sup>&#160;<italic toggle="yes">p</italic> &lt; 0.01; <sup>###</sup>&#160;<italic toggle="yes">p</italic> &lt; 0.001 versus ISO, U/L&#8212;units/liter, GOT&#8212;glutamate oxaloacetate transaminase, GPT&#8212;glutamate pyruvate transaminase, CK-MB&#8212;creatine kinase&#8211;MB isoenzyme. Each experimental group included five animals. Treatment groups and the doses administered: CONTROL&#8212;0.9% saline solution, 1 mL/rat/day, no myocardial induction of infarction; ISO&#8212;distilled water, 1 mL/rat/day + isoprenaline (150 mg/kg) s.c. on days 8 and 9 for myocardial infarction induction; MO2&#8212;<italic toggle="yes">Melilotus officinalis</italic> extract 1 mL/day by gavage, for 7 days + isoprenaline; MA2&#8212;<italic toggle="yes">Melilotus albus</italic> extract 1 mL/day by gavage, for 7 days + isoprenaline; CUM&#8212;coumarin solution by gavage 25 mg/kg, for 7 days + isoprenaline. Values are expressed as mean &#177; SD (n = 5).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="plants-14-02639-t007" orientation="portrait"><object-id pub-id-type="pii">plants-14-02639-t007_Table 7</object-id><label>Table 7</label><caption><p>ECG values determined for in vivo cardioprotective potential of MO2 and MA2 extracts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
Group
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
RR (ms)
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
HR (bpm)
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
PR (ms)
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
QRS (ms)
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
QT (ms)
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
QTc (ms)
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
ST (mV)
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CONTROL</td><td align="left" valign="middle" rowspan="1" colspan="1">0.231 *** &#177; 0.019</td><td align="left" valign="middle" rowspan="1" colspan="1">261.600 *** &#177; 21.338</td><td align="left" valign="middle" rowspan="1" colspan="1">0.049 &#177; 0.006</td><td align="left" valign="middle" rowspan="1" colspan="1">0.037 &#177; 0.006</td><td align="left" valign="middle" rowspan="1" colspan="1">0.066 *** &#177; 0.003</td><td align="left" valign="middle" rowspan="1" colspan="1">0.137 *** &#177; 0.007</td><td align="left" valign="middle" rowspan="1" colspan="1">0.030 &#177; 0.007</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ISO</td><td align="left" valign="middle" rowspan="1" colspan="1">0.144 &#177; 0.016</td><td align="left" valign="middle" rowspan="1" colspan="1">420.200 &#177; 45.008</td><td align="left" valign="middle" rowspan="1" colspan="1">0.045 &#177; 0.006</td><td align="left" valign="middle" rowspan="1" colspan="1">0.039 &#177; 0.006</td><td align="left" valign="middle" rowspan="1" colspan="1">0.103 &#177; 0.006</td><td align="left" valign="middle" rowspan="1" colspan="1">0.273 &#177; 0.013</td><td align="left" valign="middle" rowspan="1" colspan="1">0.040 &#177; 0.008</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MO2/ISO</td><td align="left" valign="middle" rowspan="1" colspan="1">0.192 <sup>##</sup> &#177; 0.061</td><td align="left" valign="middle" rowspan="1" colspan="1">337.000 <sup>###</sup> &#177; 96.374</td><td align="left" valign="middle" rowspan="1" colspan="1">0.043 &#177; 0.005</td><td align="left" valign="middle" rowspan="1" colspan="1">0.128 &#177; 0.197</td><td align="left" valign="middle" rowspan="1" colspan="1">0.093 <sup>#</sup> &#177; 0.014</td><td align="left" valign="middle" rowspan="1" colspan="1">0.221 &#177; 0.056</td><td align="left" valign="middle" rowspan="1" colspan="1">0.031 &#177; 0.008</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MA2/ISO</td><td align="left" valign="middle" rowspan="1" colspan="1">0.157 <sup>#</sup> &#177; 0.028</td><td align="left" valign="middle" rowspan="1" colspan="1">393.250 <sup>#</sup> &#177; 71.672</td><td align="left" valign="middle" rowspan="1" colspan="1">0.041 &#177; 0.009</td><td align="left" valign="middle" rowspan="1" colspan="1">0.041 &#177; 0.005</td><td align="left" valign="middle" rowspan="1" colspan="1">0.101 &#177; 0.011</td><td align="left" valign="middle" rowspan="1" colspan="1">0.256 &#177; 0.015</td><td align="left" valign="middle" rowspan="1" colspan="1">0.027 &#177; 0.009</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CUM/ISO</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.266 <sup>###</sup> &#177; 0.017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">226.600 <sup>###</sup> &#177; 14.415</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.049 &#177; 0.004</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.035 &#177; 0.002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.068 <sup>###</sup> &#177; 0.005</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.133 <sup>###</sup> &#177; 0.013</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.033 &#177; 0.004</td></tr></tbody></table><table-wrap-foot><fn><p>Note: * <italic toggle="yes">p</italic> &lt; 0.05; ** <italic toggle="yes">p</italic> &lt; 0.01; *** <italic toggle="yes">p</italic> &lt; 0.001 versus CONTROL; <sup>#</sup>&#160;<italic toggle="yes">p</italic> &lt; 0.05; <sup>##</sup>&#160;<italic toggle="yes">p</italic> &lt; 0.01; <sup>###</sup>&#160;<italic toggle="yes">p</italic> &lt; 0.001 versus ISO. Each experimental group included five animals. Treatment groups and the doses administered: CONTROL&#8212;0.9% saline solution, 1 mL/rat/day, no myocardial induction of infarction; ISO&#8212;distilled water, 1 mL/rat/day + isoprenaline (150 mg/kg) s.c. on days 8 and 9 for myocardial infarction induction; MO2&#8212;<italic toggle="yes">Melilotus officinalis</italic> extract 1 mL/day by gavage, for 7 days + isoprenaline; MA2&#8212;<italic toggle="yes">Melilotus albus</italic> extract 1 mL/day by gavage, for 7 days + isoprenaline; CUM&#8212;coumarin solution by gavage 25 mg/kg, for 7 days + isoprenaline. Values are expressed as mean &#177; SD (n = 5).</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>